<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>3
<FILENAME>g27201exv2w2.htm
<DESCRIPTION>EX-2.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;2.2</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ASSET PURCHASE AGREEMENT</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>BY</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>AND</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>BETWEEN</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>LOVELACE HEALTH SYSTEM, INC.</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>AND</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>HEART HOSPITAL OF NEW MEXICO, LLC</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Dated as of May&nbsp;6, 2011</B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="1" style="border-bottom: 0px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 1 DEFINITIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.1 Definitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.2 Interpretation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.3 Schedules</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 2 SALE OF PURCHASED ASSETS AND CERTAIN RELATED MATTERS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.1 Sale of Purchased Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.2 Excluded Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.3 Assumed Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.4 Excluded Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.5 Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.6 Interim Cash Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.7 Final Cash Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.8 Dispute of Adjustments/Reconciliation of Final Cash Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.9 Proration</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.10 No Compensation for Referrals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 3 CLOSING</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.1 Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.2 Actions of Buyer at Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.3 Actions of Seller at Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.4 Additional Acts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF BUYER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.1 Organization, Qualification and Capacity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.2 Powers; Consents; Absence of Conflicts With Other Agreements, Etc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.3 Binding Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.4 Sufficient Resources</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.5 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.6 Buyer Acknowledgements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.7 Statements True and Correct</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.8 No Other Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF SELLER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.1 Incorporation, Qualification and Capacity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.2 Powers; Consents; Absence of Conflicts With Other Agreements, Etc</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.3 Affiliates and Minority Interests</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.4 No Outstanding Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.5 Binding Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.6 Seller Financial Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.7 Permits and Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.8 Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.9 Medicare Participation/Accreditation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.10 Regulatory Compliance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->i<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="1" style="border-bottom: 0px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.11 Scheduled Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.12 Encumbrances; Real Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.13 Personal Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.14 Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.15 Employee Benefit Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.16 Hospital Employees and Employee Relations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.17 Litigation or Proceedings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.18 Tax Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.19 Environmental Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.20 Absence of Changes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.21 Medical Staff Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.22 Sufficiency of Purchased Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.23 Experimental Procedures</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.24 Supplies</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.25 Third Party Payor Cost Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.26 Compliance Program</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.27 Statements True and Correct</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.28 No Other Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 6 COVENANTS OF BUYER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.1 Notification of Certain Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.2 HSR Act Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.3 Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.4 Survey</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.5 Environmental Survey</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 7 COVENANTS OF SELLER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.1 Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.2 Operations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.3 Negative Covenants</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.4 Notification of Certain Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.5 HSR Act Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.6 Additional Financial Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.7 No-Shop Clause</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.8 Title Policy</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.9 Provider Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.10 Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 8 CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.1 Compliance With Covenants</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.2 HSR Act Waiting Period</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.3 Action/Proceeding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.4 Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.5 Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 9 CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.1 Compliance with Covenants</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.2 Pre-Closing Confirmations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.3 Action/Proceeding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->ii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="1" style="border-bottom: 0px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.4 Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.5 Transition Services Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.6 Title Policy</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.7 Absence of Certain Changes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.8 Releases</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.9 Environmental Report</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.10 Seller&#146;s Deliverables</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 10 TRANSITIONAL ARRANGEMENTS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">10.1 Transition Patients</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">10.2 Seller&#146;s Cost Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">10.3 Employees; Benefits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">10.4 Misdirected Payments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 11 ADDITIONAL AGREEMENTS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.1 Allocations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.2 Termination Prior to Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.3 Buyer Preservation and Seller Access to Records After the Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.4 Reproduction of Documents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.5 Tax Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.6 Consented Assignment and Permits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.7 Use of Controlled Substance Permits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.8 Risk of Loss; Preclosing Casualty</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.9 Change of Name</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.10 Transition Services Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.11 CVSTAT Program</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.12 Quality Reporting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.13 Supplemental Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.14 Seller&#146;s Covenant Not to Compete</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.15 Information from Virtual Data Room</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.16 MedCath Corporation Shareholder Approval</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.17 Post Closing Access to Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 12 GENERAL</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.1 Consents, Approvals and Discretion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.2 Legal Fees and Costs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.3 Choice of Law; Waiver of Jury Trial; Limitation on Damages</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.4 Benefit; Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.5 Effective Time; Accounting Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.6 No Brokerage</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.7 Cost of Transaction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.8 Confidentiality</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.9 Press Release</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.10 Waiver of Breach</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.11 Notice</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.12 Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.13 No Inferences</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.14 Divisions and Headings of this Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->iii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="1" style="border-bottom: 0px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.15 No Third-Party Beneficiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.16 Tax and Medicare Advice and Reliance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.17 Entire Agreement; Amendment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.18 Seller&#146;s Knowledge</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.19 Multiple Counterparts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.20 Disclaimer of Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.21 No Survival Period</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.22 Right to Seek Damages</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.23 Right to Take Limited Liability Company and Corporate Action</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">12.24 Guarantee of Buyer&#146;s Obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->iv<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>LIST OF SCHEDULES</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="89%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.1A</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capital Lease Obligations</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.1B</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Net Working Capital</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.1C</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Leased Real Property</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.1D</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Owned Real Property</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;2.1(f)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Software</TD>
</TR>
<TR valign="bottom">
    <TD nowrap><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;2.2(d)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Excluded Assets</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;2.2(i)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Excluded Intellectual Property</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;4.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Required Approvals for Buyer</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Outstanding Corporate Approvals</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Required Approvals for Seller</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Affiliates and Minority Interests in Seller</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rights Regarding Purchased Assets</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.6</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Historical Financial Information</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.7</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Permits</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.8</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intellectual Property</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.9</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Medicare Participation/Accreditation</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.10</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Regulatory Compliance</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.11</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Scheduled Contracts</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.14</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.15</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefit Plans</TD>
</TR>
<TR valign="bottom">
    <TD nowrap><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.16(a)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Labor Disputes</TD>
</TR>
<TR valign="bottom">
    <TD nowrap><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.16(b)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Hospital Employees</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.17</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Litigation or Proceedings against Seller</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.18</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Matters</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.19</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental Matters</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.20</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Seller Changes</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.25</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Unaudited Cost Reports</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.26</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Audits and Investigations</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;7.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Operating Covenants</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;7.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Permitted Operations</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;10.1(a)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACE Demonstration Project Payments</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;10.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">COBRA Beneficiaries</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;11.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Allocations</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;11.13</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Supplemental Insurance</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;12.18</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Persons with Knowledge</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><U><B>LIST OF EXHIBITS</B></U></TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Exhibit&nbsp;A</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Limited Power of Attorney</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Exhibit&nbsp;B</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transition Services Agreement</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->v<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ASSET PURCHASE AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THIS ASSET PURCHASE AGREEMENT </B>(this &#147;<U>Agreement</U>&#148;) is made and entered into as of May
&#95;&#95;, 2011 by and between <B>LOVELACE HEALTH SYSTEM, INC.</B>, a New Mexico corporation (&#147;<U>Buyer</U>&#148;),
and <B>HEART HOSPITAL OF NEW MEXICO, LLC</B>, a New Mexico limited liability company (&#147;<U>Seller</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>W</B></U> <U><B>I</B></U> <U><B>T</B></U> <U><B>N</B></U> <U><B>E</B></U> <U><B>S</B></U> <U><B>S</B></U> <U><B>E</B></U> <U><B>T</B></U> <U><B>H</B></U><B>:</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, Seller owns and operates the Heart Hospital of New Mexico located in Albuquerque, New
Mexico (the &#147;<U>Hospital</U>&#148;) and the Purchased Assets (as defined herein); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, in reliance upon the representations, warranties and covenants of Buyer set forth
herein, Seller desires to sell the Hospital and the Purchased Assets to Buyer, and to assign the
Assumed Liabilities to Buyer, all as more fully set forth herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NOW, THEREFORE</B>, for and in consideration of the premises, and the agreements, covenants,
representations and warranties hereinafter set forth, and other good and valuable consideration,
the receipt and adequacy of which are forever acknowledged and confessed, the parties hereto agree
as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 1</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>DEFINITIONS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>1.1 </B><U><B>Definitions</B></U>. As used herein the terms below shall have the following
meanings:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Accrued PTO</B>&#148; has the meaning set forth in Section&nbsp;2.3(d).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ACE Demonstration Project</B>&#148; has the meaning set forth in Section&nbsp;10.1(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Additional Financial Statements</B>&#148; has the meaning set forth in Section&nbsp;7.6.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Affiliate</B>&#148; means, as to the Person in question, any Person that directly or indirectly
controls, is controlled by, or is under common control with, the Person in question and any
successors or assigns of such Person; and the term &#147;control&#148; means possession, directly or
indirectly, of the power to direct or cause the direction of the management and policies of a
Person whether through ownership of voting securities, by Contract or otherwise; <U>provided</U>
that, with respect to Seller, &#147;Affiliate&#148; shall not include direct or indirect equityholders,
officers or directors of MedCath Corporation or MedCath Incorporated and shall not include any
equityholder of Seller other than Manager and its Affiliates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Agency Receivables</B>&#148; has the meaning set forth in Section&nbsp;2.2(f).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Agreement</B>&#148; means this Agreement, as amended or supplemented, together with all Exhibits and
Schedules attached or delivered with respect hereto or expressly incorporated herein by reference.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Applicable Rate</B>&#148; means the &#147;prime rate&#148; as quoted in the &#147;Money Rates&#148; section of <I>The Wall
Street Journal </I>on the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Approval</B>&#148; means any approval, authorization, consent, notice, qualification or registration,
or any extension, modification, amendment or waiver of any of the foregoing, of or from, or any
notice, statement, filing or other communication to be filed with or delivered to, any Governmental
Entity or any other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Assumed Contracts</B>&#148; has the meaning set forth in Section&nbsp;2.1(d).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Assumed Liabilities</B>&#148; has the meaning set forth in Section&nbsp;2.3.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Baseline Balance Sheet</B>&#148; means the audited balance sheet of the Hospital dated September&nbsp;30,
2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Baseline Balance Sheet Date</B>&#148; means September&nbsp;30, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Buyer</B>&#148; has the meaning set forth in the Preamble hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Capital Lease Obligations</B>&#148; means, as of the date of determination, an amount equal to the
aggregate amount outstanding under capital lease obligations of the Seller under capital leases
identified on <U>Schedule&nbsp;1.1A</U>, which capital leases are included in the Assumed Liabilities,
determined in accordance with GAAP. The amount of Capital Lease Obligations as of September&nbsp;30,
2010 was $6,188,251 as set forth on <U>Schedule&nbsp;1.1A</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>CERCLA</B>&#148; has the meaning set forth in the definition of Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Change in Control Transaction</B>&#148; means (i)&nbsp;a transaction in which a Person is or becomes the
beneficial owner, directly or indirectly, of securities of MedCath Corporation representing fifty
percent (50%) or more of the total voting power represented by MedCath Corporation&#146;s then
outstanding voting securities; (ii)&nbsp;a merger or consolidation in which MedCath Corporation is a
party and in which the equityholders of MedCath Corporation before such merger or consolidation do
not retain, directly or indirectly, at least a majority of the beneficial interest in the voting
equity interests of the Person that survives or results from such merger or consolidation; or (iii)
a sale or disposition by MedCath Corporation or its Affiliates of all or substantially all of
MedCath Corporation&#146;s assets or those of its Affiliates existing as of the date hereof (excluding
the Hospital) either to a single or multiple buyers thereof. Notwithstanding the foregoing, in no
event shall the acquisition of voting securities by one or more Persons (even if such offering
represents 50% or more of the total voting power represented by MedCath Corporation&#146;s then
outstanding voting securities) in a public offering constitute a Change in Control Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Closing</B>&#148; has the meaning set forth in Section&nbsp;3.1.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Closing Balance Sheet</B>&#148; means the balance sheet of Seller in respect of the Hospital as of the
Closing Date. The Closing Balance Sheet shall be prepared in accordance with GAAP (except as
provided in <U>Schedule&nbsp;5.6</U>), applied on a basis consistent with the Baseline Balance Sheet.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Closing Date</B>&#148; has the meaning set forth in Section&nbsp;3.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>CMS</B>&#148; has the meaning set forth in Section&nbsp;5.9(e).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>COBRA</B>&#148; has the meaning set forth in Section&nbsp;10.3(d).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986, as amended, and the rules and regulations
promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Competing Business</B>&#148; has the meaning set forth in Section&nbsp;11.14(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Confidentiality Agreement</B>&#148; has the meaning set forth in Section&nbsp;12.8.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Contract</B>&#148; means any binding written or oral contract, commitment, instrument, lease, or other
arrangement or agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Cost Reports</B>&#148; has the meaning set forth in Section&nbsp;10.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>CVSTAT License Agreement</B>&#148; has the meaning set forth in Section&nbsp;11.11.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>De Minimis Contract</B>&#148; means any Contract that either (i)&nbsp;requires total expenditures
subsequent to Closing of not more than $25,000 or (ii)&nbsp;can be terminated without cause or penalty
within ninety (90)&nbsp;days after Closing without the expenditure of more than $25,000 within such
ninety (90)&nbsp;day period, other than Contracts that (x)&nbsp;are with physicians or other referral
sources, (y)&nbsp;involve leases of the Real Property, or (z)&nbsp;would limit in any material respect the
ability of Buyer to engage in any line of business in any geographic area or to compete with any
Person, which must be scheduled.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>DRG Transition Patient</B>&#148; has the meaning set forth in Section&nbsp;10.1(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>EEOC</B>&#148; means the Equal Employment Opportunity Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Effective Time</B>&#148; has the meaning set forth in Section&nbsp;12.5.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Encumbrance</B>&#148; means any claim, charge, easement, encumbrance, conditional sales agreement,
right of first refusal, option, encroachment, security interest, mortgage, lien, pledge or
restriction, whether imposed by Contract, Law, equity or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Condition</B>&#148; as to either party, means any event, circumstance or conditions
related in any manner whatsoever to: (i)&nbsp;the current or past presence or spill, emission,
discharge, disposal, release or threatened release of any hazardous, infectious or toxic
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">substance or waste (as defined by any applicable Environmental Laws) or any chemicals,
pollutants, petroleum, petroleum products or oil (&#147;<U>Hazardous Materials</U>&#148;), into the
environment; or (ii)&nbsp;the on-site or off-site treatment, storage, disposal or other handling of any
Hazardous Material originating on or from the Real Property; or (iii)&nbsp;the placement of structures
or Hazardous Materials into waters of the United States; or (iv)&nbsp;the presence of any Hazardous
Materials in any building, structure or workplace or on any portion of the Real Property; or (v)
any violation of Environmental Laws at or on any part of the Real Property, or arising from the
activities of the Seller or any Affiliate of the Seller at the Hospital, involving Hazardous
Materials.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Laws</B>&#148; means all Laws relating to pollution or the environment, including the
Comprehensive Environmental Recovery, Compensation, and Liability Act, as amended, 42 U.S.C. &#167;
9601, <I>et seq</I>. (&#147;<U>CERCLA</U>&#148;); the Resource Conservation and Recovery Act, as amended, 42 U.S.C.
&#167; 6901, <I>et seq</I>. (&#147;<U>RCRA</U>&#148;), the Clean Air Act, 42 U.S.C &#167; 7401, <I>et seq</I>., the Occupational
Safety and Health Act, 29 U.S.C. &#167; 600, <I>et seq</I>. (&#147;<U>OSHA</U>&#148;), and all other Laws relating to
emissions, discharges, releases, or threatened releases of pollutants, contaminants, chemicals,
pesticides, or industrial, infectious, toxic or hazardous substances or wastes into the environment
(including ambient air, surface water, groundwater, land surface or subsurface strata) or otherwise
relating to the processing, generation, distribution, use, treatment, storage, disposal, transport,
or handling of pollutants, contaminants, chemicals, or industrial, infectious, toxic, or hazardous
substances or wastes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974, as amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ERISA Controlled Group</B>&#148; means a group of Persons considered to be aggregated with each other
pursuant to Section&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Excluded Assets</B>&#148; has the meaning set forth in Section&nbsp;2.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Excluded Contracts</B>&#148; has the meaning set forth in Section&nbsp;2.2(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Excluded Liabilities</B>&#148; has the meaning set forth in Section&nbsp;2.4.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Exhibits</B>&#148; means the exhibits to this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Final Capital Lease Obligations Calculation</B>&#148; means a calculation of the aggregate amount of
the Capital Lease Obligations as of the Closing Date as reflected on the Closing Balance Sheet.
The Final Capital Lease Obligations Calculation shall be prepared using the same methodologies and
assumptions used in connection with the preparation of the determination of the Capital Lease
Obligations set forth on <U>Schedule&nbsp;1.1A</U> and in a manner consistent with GAAP and the
Baseline Balance Sheet.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Final Cash Purchase Price</B>&#148; means an amount equal to (i)&nbsp;One Hundred and Nineteen Million
Dollars ($119,000,000) plus or minus (ii)&nbsp;the Final NWC Calculation minus (iii)&nbsp;Final Capital Lease
Obligations Calculation.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Final NWC Calculation</B>&#148; means a calculation of the Net Working Capital as of the Closing Date.
The Final NWC Calculation shall be prepared using the same methodologies and assumptions used in
connection with the preparation of the determination of Net Working Capital set forth on
<U>Schedule&nbsp;1.1B</U>. For the avoidance of doubt, the accounting policies, assumptions and
methodologies used for determining each of the items used in the determination of Net Working
Capital shall be the same as used in connection with the preparation of the determination of Net
Working Capital set forth on <U>Schedule&nbsp;1.1B</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>FIRPTA</B>&#148; means the Foreign Investment Real Property Tax Act of 1980, as amended, and the rules
and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Furniture and Equipment</B>&#148; means all equipment (including movable equipment), vehicles,
furniture or furnishings that are held or used by Seller primarily or exclusively in the business
or operation of the Hospital (other than Excluded Assets), including all such equipment, vehicles,
furniture or furnishings that have been fully depreciated for accounting purposes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>GAAP</B>&#148; means United States generally accepted accounting principles and practices as in effect
from time to time, as modified as described in <U>Schedule&nbsp;5.6</U> and applied consistently by
Seller throughout the periods involved and in accordance with Seller&#146;s practices and policies
utilized in its September&nbsp;30, 2010 financial statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Government Programs</B>&#148; means the federal Medicare, all applicable state Medicaid and successor
programs.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Governmental Entity</B>&#148; means any government or any agency, bureau, board, directorate,
commission, court, department, official, political subdivision, tribunal or other instrumentality
of any government, whether federal, state or local, domestic or foreign.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Hazardous Materials</B>&#148; has the meaning set forth in the definition of Environmental Condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Hired Employee</B>&#148; has the meaning set forth in Section&nbsp;10.3(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Historical Financial Information</B>&#148; has the meaning set forth in Section&nbsp;5.6(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Hospital</B>&#148; has the meaning set forth in the recitals hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Hospital Employees</B>&#148; has the meaning set forth in Section&nbsp;5.16(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>HQI Program</B>&#148; has the meaning set forth in Section&nbsp;5.9(e).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the
related regulations and published interpretations.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Intellectual Property</B>&#148; means, to the extent held or used primarily or exclusively in the
business or operation of the Hospital, patents, trademarks, trade names, service marks, copyrights
and any applications therefor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Interim Balance Sheet</B>&#148; means the balance sheet of Seller in respect of the Hospital as of the
Interim Balance Sheet Date. The Interim Balance Sheet shall be prepared in accordance with GAAP
(except as provided in <U>Schedule&nbsp;5.6</U>), applied on a basis consistent with the Baseline
Balance Sheet.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Interim Balance Sheet Date</B>&#148; means the most recently ended calendar month prior to the Closing
Date for which financial statements are available for Seller in respect of the Hospital.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Interim Capital Lease Obligations Calculation</B>&#148; means a calculation of the aggregate amount of
the Capital Lease Obligations as of the Interim Balance Sheet Date as reflected on the Interim
Balance Sheet. The Interim Capital Lease Obligations Calculation shall be prepared using the same
methodologies and assumptions used in connection with the preparation of the determination of the
Capital Lease Obligations set forth on <U>Schedule&nbsp;1.1A</U> and in a manner consistent with GAAP
and the Baseline Balance Sheet.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Interim Cash Purchase Price</B>&#148; means an amount equal to (i)&nbsp;One Hundred and Nineteen Million
Dollars ($119,000,000) plus or minus (ii)&nbsp;the Interim NWC Calculation minus (iii)&nbsp;the Interim
Capital Lease Obligations Calculation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Interim NWC Calculation</B>&#148; means a calculation of the Net Working Capital as of the Interim
Balance Sheet Date. The Interim NWC Calculation shall be prepared using the same methodologies and
assumptions used in connection with the preparation of the determination of Net Working Capital set
forth on <U>Schedule&nbsp;1.1B</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Inventory</B>&#148; means all inventory and supplies held or used in the business or operation of the
Hospital.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Law</B>&#148; means any constitutional provision, statute, ordinance or other law, rule, regulation or
order of any Governmental Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Leased Real Property</B>&#148; means all real property subject to a leasehold or subleasehold estate
(and in which Seller is the tenant or subtenant) held or used in the business or operation of the
Hospital described on <U>Schedule&nbsp;1.1C</U>, which constitutes all leasehold or subleasehold
interests held by Seller and used in the business or operation of the Hospital.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>LMC</B>&#148; has the meaning set forth in Section&nbsp;6.3.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Manager</B>&#148; means NM Hospital Management, LLC, a North Carolina limited liability company and
the manager of Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Material Adverse Effect</B>&#148; shall mean any fact, circumstance, event, change, effect, condition
or occurrence that, individually or in the aggregate, has had or is reasonably likely to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">have a material adverse effect on the business, operations, property, financial condition or
results of operations of the Purchased Assets and the Hospital, taken as a whole; <U>provided</U>,
<U>however</U>, that any adverse effect arising out of, resulting from or attributable to any of
the following shall not constitute or be deemed to contribute to a Material Adverse Effect, and
otherwise shall not be taken into account in determining whether a Material Adverse Effect has
occurred: (i)&nbsp;a fact, circumstance, event, change, effect or occurrence, or series of such items,
to the extent affecting (A)&nbsp;global, national or regional economic, business, regulatory, market or
political conditions or national or global financial markets, including changes in interest or
exchange rates or (B)&nbsp;the healthcare industry generally, (ii)&nbsp;the negotiation, execution or the
announcement of, or the performance of obligations under, this Agreement, the Schedules or the
other documents contemplated by this Agreement or the consummation of the transactions contemplated
hereby, (iii)&nbsp;any changes or any proposed changes in Law or GAAP or the enforcement or
interpretation thereof, (iv)&nbsp;any actions taken with the specific written consent of or at the
written request of Buyer, (v)&nbsp;any hostilities, acts of war, sabotage, terrorism or military
actions, or any escalation or worsening of any such hostilities, act of war, sabotage, terrorism or
military actions, or (vi)&nbsp;the implementation of the Patient Protection and Affordable Care Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Medicaid</B>&#148; means Title XIX of the Social Security Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Medicare</B>&#148; means Title XVIII of the Social Security Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Net Working Capital</B>&#148; means, as of the date of determination, an amount equal to the following
with respect to the Seller, in each instance as determined in accordance with GAAP, consistently
applied: (a)&nbsp;the sum of the amounts reflected in the entries (or line items) on the applicable
balance sheet entitled (i) &#147;Inventories;&#148; and (ii) &#147;Prepaid expenses;&#148;; minus (b)&nbsp;the amounts
reflected in the entries (or line items) on the applicable balance sheet entitled &#147;Accrued PTO&#148;-
which is further defined herein. &#147;Inventories&#148; shall be comprised in all material respects of
Inventory used or useful in respect of the Hospital, with obsolete items written off. &#147;Prepaid
expenses&#148; shall be limited to prepaid expenses which are useable by Buyer after Closing in the
operation of the Hospital. For avoidance of doubt, the parties agree that no other amounts
reflected in the entries (or line items) on the applicable balance sheet shall be considered in
determining Net Working Capital. Net Working Capital shall be prepared in accordance with GAAP
(except as provided in <U>Schedule&nbsp;5.6</U>), applied on a basis consistent with past practices
using the same policies, methodologies and assumptions used in connection with the preparation of
the determination of Net Working Capital set forth on <U>Schedule&nbsp;1.1B</U>. The Net Working
Capital as of September&nbsp;30, 2010 was $1,617,881<B>, </B>as set forth on <U>Schedule&nbsp;1.1B</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ORYX</B>&#148; has the meaning set forth in Section&nbsp;5.9(e).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>OSHA</B>&#148; has the meaning set forth in the definition of Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Outside Date</B>&#148; has the meaning set forth in Section&nbsp;11.2(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Owned Real Property</B>&#148; means all the real property described on <U>Schedule&nbsp;1.1D</U>, which
constitutes all real property both (a)&nbsp;owned by Seller or owned by any Seller Affiliate and (b)
held or used in the business or operation of the Hospital, together with all leases and subleases
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">therein, improvements, buildings or fixtures located thereon or therein, all easements, rights
of way, and other appurtenances thereto (including appurtenant rights in and to public streets),
and all claims and recorded or unrecorded interests therein, including any and all options to
acquire such real property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Permit</B>&#148; means any license or permit required to be issued by any Governmental Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Permitted Encumbrance</B>&#148; means any Encumbrance that is (i)&nbsp;a lien for Taxes not yet due and
payable, (ii)&nbsp;a lien securing any Capital Lease Obligation or Assumed Liability, (iii)&nbsp;a lease
obligation under any Scheduled Contract set forth on <U>Schedule&nbsp;5.11</U>, which is assumed in
writing by Buyer, (iv)&nbsp;an Encumbrance reflected on the Survey described in Section&nbsp;6.4 that is
reasonably approved by Buyer and that does not materially interfere with the operations of the
Purchased Assets in a manner consistent with the current use by Seller, and (v)&nbsp;an exception listed
in Schedule&nbsp;B &#151; Section&nbsp;II of the title commitment obtained from the Title Company prior to the
Closing Date (&#147;<U>Title Commitment</U>&#148;) that is reasonably approved by Buyer and that does not
materially interfere with the operations of the Purchased Assets in a manner consistent with the
current use by Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Person</B>&#148; means an association, a corporation, a limited liability company, an individual, a
partnership, a limited liability partnership, a trust or any other entity or organization,
including a Governmental Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Phase I Assessment</B>&#148; has the meaning set forth in Section&nbsp;6.5.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Plans</B>&#148; has the meaning set forth in Section&nbsp;5.15(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Purchased Assets</B>&#148; has the meaning set forth in Section&nbsp;2.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>QNet</B>&#148; has the meaning set forth in Section&nbsp;5.9(e).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>RCRA</B>&#148; has the meaning set forth in the definition of Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Real Property</B>&#148; means the Owned Real Property and the Leased Real Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Restricted Area</B>&#148; has the meaning set forth in Section&nbsp;11.14(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Retirement Plans</B>&#148; has the meaning set forth in Section&nbsp;5.15(g).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Scheduled Contracts</B>&#148; has the meaning set forth in Section&nbsp;5.11.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Schedules</B>&#148; means the disclosure schedules to this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Seller</B>&#148; has the meaning set forth in the Preamble hereto.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Seller Affiliate</B>&#148; means Seller, the Manager and any Affiliate of Seller. Without limiting
the foregoing, Seller Affiliate shall not include any physician or Affiliate of a physician that is
or has been a direct or indirect member of Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Separation Date</B>&#148; has the meaning set forth in Section&nbsp;10.3(d).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Survey</B>&#148; has the meaning set forth in Section&nbsp;6.4.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Taxes</B>&#148; has the meaning set forth in Section&nbsp;5.18(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Title Commitment</B>&#148; has the meaning set forth in the definition of Permitted Encumbrance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Title Company</B>&#148; means Land Services USA, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Transition Patients</B>&#148; has the meaning set forth in Section&nbsp;10.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Transition Patient Services</B>&#148; has the meaning set forth in Section&nbsp;10.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Transition Services Agreement</B>&#148; has the meaning set forth in Section&nbsp;11.10.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>TRICARE</B>&#148; means the Department of Defense&#146;s managed healthcare program for active duty
military, active duty service families, retirees and their families and other beneficiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>WARN Act</B>&#148; has the meaning set forth in Section&nbsp;10.3(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>1.2 </B><U><B>Interpretation</B></U>. In this Agreement, unless the context otherwise requires:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) references to this Agreement are references to this Agreement and to the
Exhibits and Schedules;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) references to Articles and Sections are references to articles and sections of
this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) references to any party to this Agreement shall include references to its
respective successors and permitted assigns;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) references to a judgment shall include references to any order, writ,
injunction, decree, determination or award of any court or tribunal or arbitrator in a
binding arbitration;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the terms &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby,&#148; and derivative or similar words will
refer to this entire Agreement;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) references to any document (including this Agreement) are references to that
document as amended, consolidated, supplemented, novated or replaced by the parties from
time to time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) unless the context requires otherwise, references to any Law are references to
that Law as of the Closing Date, and shall also refer to all rules and regulations
promulgated thereunder;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) the word &#147;including&#148; (and all derivations thereof) shall mean including,
without limitation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) references to time are references to Mountain Standard or Daylight time (as in
effect on the applicable day) unless otherwise specified herein;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) the gender of all words herein include the masculine, feminine and neuter, and
the number of all words herein include the singular and plural;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) provisions of this Agreement shall be interpreted in such a manner so as not to
inequitably benefit or burden any party through &#147;double counting&#148; of assets or liabilities
or failing to recognize benefits that may result from any matters that impose losses or
burdens on any party, including in connection with the determination of the Final Cash
Purchase Price and the calculation of losses on casualty claims;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) the terms &#147;date hereof,&#148; &#147;date of this Agreement&#148; and similar terms shall mean
the date set forth in the opening paragraph of this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) the section headings and subheadings in this Agreement and the Schedules are
for convenience of reference only and shall not affect the meaning or interpretation of this
Agreement or the express description of the Schedules.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>1.3 </B><U><B>Schedules</B></U>. Buyer and Seller hereby acknowledge and agree as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Schedules and any disclosures made in or by virtue of them are integral
parts of this Agreement as if fully set forth in this Agreement and all statements appearing
therein shall be deemed to be representations;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the fact that any items of information are contained in the Schedules shall not
be construed as an admission of liability under any applicable law, or to mean that such
information is required to be disclosed in or by this Agreement, or to mean that such
information is material. Such information shall not be used as a basis for interpreting the
terms &#147;material,&#148; &#147;materially,&#148; &#147;materiality&#148; or any similar qualification in the Agreement.
Nothing in the Schedules constitutes an admission of any liability or obligation of Seller
to any third party, nor an admission against Seller&#146;s interest; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) items disclosed on one particular Schedule relating to one section of the
Agreement are deemed to be constructively disclosed or listed on other Schedules
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">relating to other sections of the Agreement to the extent it is reasonably apparent on
the face of such other Schedules that such disclosure is applicable to such other Schedules.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 2</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>SALE OF PURCHASED ASSETS AND CERTAIN RELATED MATTERS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.1 </B><U><B>Sale of Purchased Assets</B></U>. At Closing and subject to the terms and conditions
of this Agreement, other than the Excluded Assets, Seller shall sell, transfer, convey, assign and
deliver to Buyer, and Buyer shall purchase from Seller, all rights, title, and interest in and to
all assets of every description, and whether real, personal or mixed, tangible or intangible, owned
or leased by Seller and held or used in the business or operation of the Hospital, including the
following items (collectively, the &#147;<U>Purchased Assets</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All Furniture and Equipment;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Good and marketable title in fee simple absolute to the Owned Real Property,
and, to the extent permitted by law, any rights of Seller against third parties related to
any such Owned Real Property, together with all plants, buildings, structures, improvements,
construction in progress, appurtenances, covenants, easements, servitudes and fixtures
situated thereon, forming a part thereof, or in any manner belonging to or pertaining to
such interests of Seller;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Seller&#146;s interest in the Contracts relating to the Leased Real Property;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) (i)&nbsp;All of the interest of Seller or its Affiliates in all Scheduled Contracts in
respect of the Purchased Assets, (ii)&nbsp;all Contracts that both are not listed on <U>Schedule
5.11</U> and that are De Minimis Contracts that relate primarily or exclusively to the
operations of the Hospital and, (iii)&nbsp;all Contracts representing Capital Lease Obligations
(collectively, the &#147;<U>Assumed Contracts</U>&#148;), but excluding (i)&nbsp;except as otherwise
provided herein, Contracts relating to Plans and (ii)&nbsp;the Excluded Contracts;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) All Permits and Approvals issued or granted by Governmental Entities to the
extent assignable under applicable Law and which are held or used by the Seller Affiliates
and relate to the ownership, development and business or operation of the Purchased Assets
(including any pending Permits and Approvals related to any Purchased Assets);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) All computer hardware, software, and data processing equipment owned by Seller
or used primarily in the business or operation of the Hospital or the operation of the
Purchased Assets which, in the case of software, is listed on <U>Schedule&nbsp;2.1(f)</U> unless
it is a De Minimis Contract, and, to the extent assignable or transferable, all rights in
all warranties of any manufacturer or vendor with respect thereto;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) All Inventory;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Assumable prepaid expenses, claims for refunds and rights to offset in respect
thereof (in each case to the extent included in the Final NWC Calculation);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To the extent transferable or assignable under applicable Law, all financial,
patient and medical staff records held or used by the Seller Affiliates primarily or
exclusively in the business or operation of the Hospital (but specifically excluding any
records maintained by Affiliates of Seller in connection with the provision of services by
such Affiliates for the benefit of Seller);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) All Intellectual Property, including Seller&#146;s rights in the name Heart Hospital
of New Mexico;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) Seller&#146;s goodwill in respect of the Purchased Assets and the Hospital; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) All records related to the business, operation or ownership of the Hospital
including ad valorem and gross receipts Tax returns and records including federal forms 940,
941, W-2, W-3 and New Mexico Forms CRS-1 (but specifically excluding income Tax returns,
franchise Tax returns and supporting materials for such returns such as working papers and
Tax provisions).
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Seller shall transfer and convey good and marketable title to the Purchased Assets and all parts
thereof to Buyer, free and clear of all Encumbrances except for the Permitted Encumbrances.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.2 </B><U><B>Excluded Assets</B></U>. Notwithstanding anything to the contrary, Seller is not
selling, and Buyer is not purchasing or assuming obligations with respect to, the following assets
which shall remain the property of Seller after the Closing (the &#147;<U>Excluded Assets</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All restricted and unrestricted cash and cash equivalents, including
investments in marketable securities, certificates of deposit, bank accounts and promissory
notes, except to the extent such assets are included in the determination of the Final NWC
Calculation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) All (i)&nbsp;group Contracts entered into by MedCath Corporation or MedCath
Incorporated for the benefit of Seller and one or more Seller Affiliate, (ii)&nbsp;Contracts with
managed care organizations, health maintenance organizations, insurers and similar third
party payors, (iii)&nbsp;Contracts that are both not listed on <U>Schedule&nbsp;5.11</U> and that are
not De Minimis Contracts that relate to the operations of the Hospital, and (iv)&nbsp;Contracts
listed as Excluded Contracts on <U>Schedule&nbsp;5.11</U> (collectively, the &#147;<U>Excluded
Contracts</U>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The corporate record books, minute books, and corporate seals and all records
of any kind that Seller is required by Law to retain in its own possession together with
those records maintained by Seller with respect to its Affiliates;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Such other property and assets, if any, specifically described on <U>Schedule
2.2(d)</U>;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Any claims or rights against third parties related to the Purchased Assets
(including the Assumed Contracts), contractual or otherwise, accruing or arising prior to
the Closing, except to the extent (i)&nbsp;included in the determination of the Final NWC
Calculation or (ii)&nbsp;such claim or right would also relate to a period after Closing, but
only to the extent such right or claim relates to periods after Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) All rights to settlement and retroactive adjustments, if any, for open cost
reporting periods ending on or prior to the Closing Date (whether open or closed) arising
from or against the U.S. Government under the terms of the Medicare program or TRICARE and
against any state under its Medicaid program and against any third-party payor programs that
settle on a cost report basis (&#147;<U>Agency Receivables</U>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) All rights of Seller under this Agreement or any agreement contemplated hereby;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) All (i)&nbsp;claims for refunds of Taxes and all other Tax assets for periods prior
to the Closing, (ii)&nbsp;Federal and State income tax returns for periods prior to the Closing,
and (iii)&nbsp;books and records created for the purpose of complying with Federal and State Tax
Laws;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) All data processing equipment, proprietary computer software and Intellectual
Property utilized in connection with the provision of services by Affiliates of Seller for
the benefit of Seller that are listed on <U>Schedule&nbsp;2.2(i)</U>, and, in the case of
software, all software unless listed on <U>Schedule&nbsp;2.1(f)</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) All accounts receivable of Seller, and all rights to payment, whether billed or
unbilled, recorded or unrecorded, accrued and existing, whether or not written off, in
connection with the operation of the Hospital on or prior to the Closing Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The names and symbols used in connection with the Hospital and the Purchased
Assets which include the name &#147;MedCath&#148; or any variants thereof, or any other names which
are proprietary to the Seller or its Affiliates, other than &#147;Heart Hospital of New Mexico&#148;;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) Any proprietary information contained in (i)&nbsp;Seller&#146;s employee or operation
manuals or (ii)&nbsp;any films or videos used by Seller for operational or training purposes;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) All intercompany accounts of Seller and its Affiliates;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) All of Seller&#146;s insurance proceeds arising in connection with the operation of
the Hospital or the Purchased Assets prior to Closing, except to the extent provided in
Section&nbsp;11.8;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) All assets used by Seller and its Affiliates in rendering corporate services to
the Seller Affiliates or the Hospital that are located outside the Hospital, except to the
extent such assets are reflected in the Final NWC Calculation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) Any assets used or operated by MedCath Corporation or MedCath Incorporated on a
company-wide or region-wide basis, unless such assets are reflected in the Final NWC
Calculation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) To the extent permitted by Sections&nbsp;7.2 and 7.3 hereof, all assets disposed of
or exhausted prior to Closing, including Inventory, prepaid expenses and Furniture and
Equipment, except to the extent such assets are included in the determination of the Final
NWC Calculation; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) All provider numbers and related agreements related to any Government Programs
and TRICARE.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.3 </B><U><B>Assumed Liabilities</B></U>. As of Closing, Buyer agrees to assume the future payment
and performance of the following liabilities of Seller and its Affiliates (collectively, the
&#147;<U>Assumed Liabilities</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all obligations and liabilities that arise or accrue after Closing under the
Assumed Contracts;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Capital Lease Obligations;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) subject to the provisions of Section&nbsp;2.9, ad valorem and personal property
Taxes payable for the calendar year in which the Closing Date occurs;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) obligations and liabilities as of the Closing Date in respect of (i)&nbsp;accrued
paid time off of Hired Employees (including employer FICA and any other estimated employer
taxes thereon) and accrued Extended Service Recognition leave (including employer FICA and
any other estimated employer taxes thereon) (&#147;<U>ESR Leave</U>&#148;) of Hired Employees who
have completed six (6)&nbsp;years of eligibility service with Seller as of the Closing Date
(collectively, the &#147;<U>Accrued PTO</U>&#148;), but only to the extent such Accrued PTO
(including, for purposes of clarification, ESR Leave) is included in the determination of
the Final NWC Calculation and (ii)&nbsp;the COBRA liabilities and obligations set forth in
Section&nbsp;10.3(c) hereof; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any state and local transfer, sales, and recording fees and similar Taxes which
may arise upon the consummation of the transactions contemplated herein (excluding, for the
avoidance of doubt, any Taxes measured by income or gain). Buyer shall be responsible for,
and Seller will collect from Buyer, any amount of New Mexico Gross Receipts Tax due as a
result of the contemplated transaction, the payment of which by Buyer shall be in addition
to any other obligations of Buyer under this Agreement. Seller shall be responsible for
remitting such Tax to the appropriate taxing authority.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.4 </B><U><B>Excluded Liabilities</B></U>. Except as expressly provided to the contrary in Section
2.3 with respect to Assumed Liabilities, Buyer is not obligated to pay or assume any liability of
any
type or nature, including the following, whether fixed or contingent, recorded or unrecorded,
known or unknown (collectively, the &#147;<U>Excluded Liabilities</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) current liabilities, accounts payable, long-term liabilities, and all
indebtedness and obligations or guarantees of Seller, except to the extent included in the
Final Capital Lease Obligations Calculation or the determination of the Final NWC
Calculation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any obligation or liability accruing or arising during the period prior to
Closing in connection with (i)&nbsp;any Assumed Contract (other than that which may arise from
the failure to obtain the consent of the counter-party thereto of any Assumed Contract),
(ii)&nbsp;the operation of the Hospital, including all malpractice and general liability claims,
whether or not same are pending, threatened, known or unknown prior to Closing, or (iii)&nbsp;any
Governmental Programs or other third-party payor programs, including recoupment of
previously paid or reimbursed amounts, and any Cost Report settlement payables relating to
all Cost Report periods ending on or before the Closing Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any obligation or liability accruing, arising out of, or relating to any
Excluded Contract;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) (i)&nbsp;any federal, state or local Tax obligations of Seller and its Affiliates in
respect of periods (or portions thereof) ending on or prior to Closing, including any income
Tax, any franchise Tax, any Tax recapture and any sales and/or use Tax and any payroll or
withholding Tax (other than any ad valorem and personal property Taxes and state and local
transfer, sales, and recording fees and Taxes which may arise upon the consummation of the
transactions contemplated herein) that are not included in the Final NWC Calculation or
prorated as of Closing and (ii)&nbsp;federal, state or local income Tax obligations or
liabilities of Seller and its Affiliates resulting from the consummation of the transactions
contemplated by this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any obligation or liability for claims by or on behalf of employees of Seller
and its Affiliates relating to periods prior to Closing, including liability for any
pension, profit sharing, deferred compensation, or any other employee health and welfare
benefit plans, liability for any EEOC claim, wage and hour claim, unemployment compensation
claim or workers&#146; compensation claim, and liability for all employee wages and benefits,
including accrued vacation and holiday pay and Taxes or other liability related thereto in
respect of employees of Seller and its Affiliates, except to the extent that accruals for
such obligations are included in the determination of the Final NWC Calculation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) any obligation or liability accruing, arising out of, or relating to any
federal, state or local investigations of, or claims or actions against, Seller or any of
its Affiliates or any of their employees, medical staff, agents, vendors or representatives
which existed or occurred prior to Closing; and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) any obligation or liability accruing, arising out of or relating to any
violation of, or non-compliance with, Law pertaining to the Purchased Assets, the Hospital
or the operation thereof, which existed or occurred prior to Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.5 </B><U><B>Purchase Price</B></U>. Subject to the terms and conditions hereof, in reliance on
the representations and warranties herein set forth and as consideration for the sale and purchase
of the Hospital and the Purchased Assets set forth herein, in addition to assuming the Assumed
Liabilities, Buyer shall tender to Seller an amount equal to the Final Cash Purchase Price. On the
Closing Date, Buyer shall wire transfer an amount equal to the Interim Cash Purchase Price in
immediately available federal funds to an account designated by Seller in writing at least two (2)
business days prior to Closing. The amount of the Interim Cash Purchase Price will be further and
finally adjusted and settled after Closing as provided in Section&nbsp;2.7.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.6 </B><U><B>Interim Cash Purchase Price</B></U>. At least five (5)&nbsp;business days prior to the
Closing Date Seller shall deliver to Buyer (i)&nbsp;the Interim Balance Sheet, (ii)&nbsp;the Interim NWC
Calculation and (iii)&nbsp;the Interim Capital Lease Obligations Calculation. Based upon such exchange
of information, the parties shall determine, calculate, and agree, in writing, upon the Interim
Cash Purchase Price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.7 </B><U><B>Final Cash Purchase Price</B></U>. Not more than forty-five (45)&nbsp;days after the
Closing Date, Seller shall deliver to Buyer (i)&nbsp;the Closing Balance Sheet, (ii)&nbsp;the Final NWC
Calculation and (iii)&nbsp;the Final Capital Lease Obligations Calculation. Subject to Section&nbsp;2.8,
based upon such exchange of information, the parties shall determine, calculate and agree, in
writing, upon the Final Cash Purchase Price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.8 </B><U><B>Dispute of Adjustments/Reconciliation of Final Cash Purchase Price</B></U>. Within
thirty (30)&nbsp;days after the date on which Buyer has received the information to be provided by
Seller pursuant to Section&nbsp;2.7, Buyer shall, in a written notice to Seller, either accept or
describe in reasonable detail any proposed adjustments to the calculations exchanged and the
reasons therefor, and shall include pertinent calculations. If Buyer fails to deliver notice of
acceptance or objection to such calculations within such thirty (30)&nbsp;day period, then Buyer shall
be deemed to have accepted the calculations presented by Seller. In the event that Buyer and
Seller are not able to agree on the Final Cash Purchase Price within thirty (30)&nbsp;days from and
after the receipt by Seller of any objections raised by Buyer, Buyer and Seller shall each have the
right to require that such disputed determination be submitted to such independent certified public
accounting firm as Buyer and Seller may then mutually agree upon in writing for computation or
verification in accordance with the provisions of this Agreement. The results of such accounting
firm&#146;s report shall be binding upon Buyer and Seller, and such accounting firm&#146;s fees and expenses
for each disputed determination shall be borne equally by the parties. Appropriate payment shall
be made by Buyer or Seller, as appropriate, by wire transfer of immediately available federal funds
promptly upon (and in all events within three (3)&nbsp;business days after) agreement between Seller and
Buyer on the Final Cash Purchase Price or determination of the Final Cash Purchase Price in
accordance with this Section as follows: either (i)&nbsp;Buyer shall pay Seller the amount by which the
Final Cash Purchase Price exceeds the Interim Cash Purchase Price or (ii)&nbsp;Seller shall pay Buyer
the amount by which the Interim Cash Purchase Price exceeds the Final Cash Purchase
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Price. At all
reasonable times following delivery by Seller of the information and calculations
required by Section&nbsp;2.7, Seller shall make available to Buyer and its agents all books and
records of Seller related to the determination of the Interim Cash Purchase Price and the Final
Cash Purchase Price, including all accounting work papers and journal entries underlying the
determination of the Interim Cash Purchase Price and the Final Cash Purchase Price or any component
thereof. Any amounts due under this Section&nbsp;2.8 shall bear interest from the Closing Date until
paid at a rate equal to the Applicable Rate per annum.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.9 </B><U><B>Proration</B></U>. To the extent feasible, at the Closing, Buyer and Seller shall
prorate as of the Closing Date, in accordance with their respective obligations herein, any costs
or payments relating to the Purchased Assets that relate to periods both before and after Closing
which become due and payable after the Closing Date with respect to (i)&nbsp;the Assumed Contracts, (ii)
ad valorem or similar Taxes, duties or fees, if any, on the Real Property, (iii)&nbsp;personal property
Taxes on the Purchased Assets, and (iv)&nbsp;all utilities servicing the Hospital, including water,
sewer, telephone, electricity and gas service, in each case to the extent not included on the
determination of the Final NWC Calculation. Any above-described obligations which are not known at
least five (5)&nbsp;business days prior to the Closing Date shall be similarly apportioned, subject to
the above, and paid by the responsible party as soon as practicable after the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.10 </B><U><B>No Compensation for Referrals</B></U>. Buyer and Seller agree that neither this
Agreement nor any other Contract entered into in connection with the transactions contemplated by
this Agreement requires, is payment for, or is contingent upon the admission or referral of any
patient to, or the provision of any item or medical services by, (i)&nbsp;Buyer or its Affiliates, (ii)
Seller, its Affiliates or any direct or indirect equityholders of Seller or MedCath Corporation,
(iii)&nbsp;the Hospital, or (iv)&nbsp;any healthcare facility owned by or affiliated with Buyer or Seller.
The parties acknowledge that no party who may receive any benefit from the transactions
contemplated by this Agreement, including without limitation New Mexico Heart Institute, Southwest
Cardiology Associates or any other direct or indirect owner of Seller who is a physician, immediate
family member of a physician, or entity owned or controlled by any physician, has any obligation to
refer patients to Buyer, the Hospital, or any healthcare facility owned by or affiliated with the
Buyer, and that all such referrals shall be based only upon the professional medical judgment of
the referring physician, the medical needs of the patient, and patient choice.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 3</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CLOSING</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>3.1 </B><U><B>Closing</B></U>. Subject to the satisfaction or waiver by the appropriate party of
all the conditions precedent to Closing specified in Articles 8 and 9, the consummation of the sale
and purchase of the Hospital and the Purchased Assets and the other transactions contemplated by
and described in this Agreement (the &#147;<U>Closing</U>&#148;) shall take place at the offices of Moore &#038;
Van Allen PLLC, Suite&nbsp;4700, 100 North Tryon Street, Charlotte, North Carolina 28202, not later than
the fifth (5th) business day after the conditions set forth in Articles 8 and 9 have been satisfied
or waived or at such other date and/or at such other location as the parties hereto may mutually
designate in writing (the &#147;<U>Closing Date</U>&#148;). Subject to the other terms of this Agreement,
the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">parties shall use commercially reasonable efforts to cause the conditions set forth in Articles
8 and 9 to be satisfied so that the Closing will occur on July&nbsp;31, 2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>3.2 </B><U><B>Actions of Buyer at Closing</B></U>. At the Closing and unless otherwise waived in
writing by Seller, Buyer shall deliver to Seller the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) An amount equal to the Interim Cash Purchase Price by wire transfer of
immediately available funds to an account designated by Seller;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) One or more Assignments of Contracts and Assumption of Liabilities duly
executed by Buyer, pursuant to which Buyer shall assume the future payment and performance
of the Assumed Contracts and the Assumed Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Copies of resolutions duly adopted by the board of directors of Buyer,
authorizing and approving Buyer&#146;s performance of the transactions contemplated hereby and
the execution and delivery of this Agreement and the documents described herein, certified
as true and of full force and effect as of Closing, by the appropriate officers of Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) A certificate of Buyer certifying that the conditions set forth in Sections&nbsp;8.1
and 8.4 have been satisfied;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Certificates of incumbency for the respective officers of Buyer executing this
Agreement and any other document contemplated herein dated as of the Closing Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Certificates of existence and good standing of Buyer from its state of
organization dated the most recent practical date prior to Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The Transition Services Agreement, duly executed by Buyer; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Such other instruments and documents Seller reasonably deems necessary to
effect the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>3.3 </B><U><B>Actions of Seller at Closing</B></U>. At the Closing and unless otherwise waived in
writing by Buyer, Seller shall deliver to Buyer the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Subject only to the Permitted Encumbrances, deeds containing special warranty
of title, duly executed by Seller in recordable form, conveying to Buyer good and marketable
fee simple absolute title to the Owned Real Property;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) One or more assignments of lease, duly executed by Seller assigning to Buyer
Seller&#146;s interest in the Contracts relating to any Leased Real Property;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) One or more assignments of lease, duly executed by Seller or one of its
Affiliates, assigning to Buyer Seller&#146;s interest as lessor under or sublessor under
Contracts that lease space to third parties;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) One or more Bills of Sale and Assignment, duly executed by Seller transferring
to Buyer valid title to all tangible assets which are a part of the Purchased Assets and
valid title to all intangible assets which are a part of the Purchased Assets, free and
clear of all Encumbrances other than the Assumed Liabilities and the Permitted Encumbrances;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) One or more Assignments of Contracts and Assumption of Liabilities duly
executed by Seller assigning Seller&#146;s interest in the Assumed Contracts to Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Copies of resolutions duly adopted by Seller and the Manager, authorizing and
approving Seller&#146;s performance of the transactions contemplated hereby and the execution and
delivery of this Agreement and the documents described herein, certified as true and in full
force and effect as of Closing by an appropriate officer of the Manager;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) A certificate of Seller certifying that the conditions set forth in Section&nbsp;9.1
and Section&nbsp;9.4 have been satisfied;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Certificates of incumbency for the respective officers of the Manager executing
this Agreement and any other document contemplated herein dated as of the Closing Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Certificates of existence and good standing of Seller and Manager from their
respective states of organization dated the most recent practical date prior to Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) A FIRPTA certificate, executed by Seller certifying Seller&#146;s U.S. taxpayer
identification number and that Seller is not a foreign Person, within the meaning of Section
1445 of the Code;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The Transition Services Agreement, duly executed by the appropriate Affiliate
of Seller; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) Such other instruments and documents as Buyer reasonably deems necessary to
effect the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>3.4 </B><U><B>Additional Acts</B></U>. From time to time after Closing, Seller shall execute and
deliver such other instruments of conveyance and transfer, and take such other actions as Buyer
reasonably may request, to convey and transfer full right, title and interest to, vest in, and
place Buyer in legal and actual possession of, any and all of the Purchased Assets. Seller shall
also furnish Buyer with such information and documents in its possession or under their control, or
which Seller can execute or cause to be executed, as will enable Buyer to prosecute any and all
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">petitions, applications, claims and demands relating to or constituting a part of the Purchased
Assets.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 4</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF BUYER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date hereof and as of the Closing Date (except to the extent any of the following
speaks as of a specific date, such as the date hereof), Buyer represents and warrants to Seller the
following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.1 </B><U><B>Organization, Qualification and Capacity</B></U>. Buyer is a corporation duly
organized and validly existing in good standing under the Laws of the State of New Mexico. The
execution and delivery by Buyer of this Agreement and the documents described herein, the
performance by Buyer of its obligations under this Agreement and the documents described herein and
the consummation by Buyer of the transactions contemplated by this Agreement and the documents
described herein have been duly and validly authorized and approved by all necessary actions on the
part of Buyer, none of which actions have been modified or rescinded and all of which actions
remain in full force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.2 </B><U><B>Powers; Consents; Absence of Conflicts With Other Agreements, Etc.</B></U> The
execution, delivery and performance of this Agreement and the documents described herein by Buyer
and the consummation by Buyer of the transactions contemplated by this Agreement and documents
described herein, as applicable:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) are not in contravention or violation of the terms of the certificate of
incorporation, limited partnership agreement, operating agreement or similar governing
document of Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) except as set forth on <U>Schedule&nbsp;4.2</U>, do not require any material
Approval or Permit of, or filing or registration with, or other action by, any Governmental
Entity to be made or sought by Buyer or any of its Affiliates; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) will not conflict in any material respect with, nor result in any material
breach or contravention of, any material Contract to which Buyer is a party or by which
Buyer is bound.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.3 </B><U><B>Binding Agreement</B></U>. This Agreement and all documents to which Buyer or any of
its Affiliates will become a party hereunder are and will constitute the valid and legally binding
obligations of Buyer and/or such Affiliates and are and will be enforceable against it in
accordance with the respective terms hereof or thereof, except as enforceability may be restricted,
limited or delayed by applicable bankruptcy or other Laws affecting creditors&#146; rights generally and
except as enforceability may be subject to general principles of equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.4 </B><U><B>Sufficient Resources</B></U>. Buyer has sufficient financial resources, and at the
Closing Buyer will possess sufficient funds, to permit Buyer to deliver the Interim Cash Purchase
Price in accordance with Section&nbsp;2.5 and the Final Cash Purchase Price in accordance
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with Section
2.7, subject to satisfaction of the conditions precedent to Buyer&#146;s obligations to close the
transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.5 </B><U><B>Litigation</B></U>. There is no claim, action, suit, proceeding or investigation
pending or, to the knowledge of Buyer, threatened in writing against or affecting Buyer that has or
would
reasonably be expected to have a material adverse effect on the ability of Buyer to perform
this Agreement or any aspect of the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.6 </B><U><B>Buyer Acknowledgements</B></U>. The decision of Buyer to purchase the Purchased
Assets and to assume the Assumed Liabilities has been (i)&nbsp;made voluntarily and of its own accord,
based upon, (A)&nbsp;the knowledge and experience of Buyer in financial and business matters relating to
owning and operating general acute care hospitals, (B)&nbsp;consultations with advisors of Buyer, and
(C)&nbsp;its investigation of the business, assets, risks and prospects of the Hospital and Purchased
Assets and (ii)&nbsp;made without relying on any statement (whether oral or written), or any
representation or warranty of, Seller or any Affiliate, officer or director of Seller, other than
the representations and warranties expressly contained in this Agreement and the other Contracts
executed at the Closing in connection herewith. As of the date hereof, Buyer has no knowledge of
any facts or circumstances which constitute or are reasonably likely to constitute a breach of the
representations and warranties of Seller set forth in Article&nbsp;5 of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.7 </B><U><B>Statements True and Correct</B></U>. This Agreement and the Schedules prepared by
Buyer do not include, as of the date hereof and as of the Closing Date, any untrue statement of a
material fact or omit to state any material fact necessary to make the statements made in this
Agreement with respect to Buyer not misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>4.8 </B><U><B>No Other Representations and Warranties</B></U>. EXCEPT FOR THE REPRESENTATIONS AND
WARRANTIES CONTAINED IN THIS ARTICLE 4 (INCLUDING THE SCHEDULES), BUYER MAKES NO EXPRESS OR IMPLIED
REPRESENTATION OR WARRANTY, AND BUYER HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY WITH
RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE CONSUMMATION OF THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 5</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF SELLER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date hereof and as of the Closing Date (except to the extent any of the following
speaks as of a specific date, such as the date hereof), Seller represents and warrants to Buyer the
following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.1 </B><U><B>Incorporation, Qualification and Capacity</B></U>. Seller is a limited liability
company duly organized and in existence under the Laws of the State of New Mexico. The Manager is
a limited liability company duly organized and validly existing in good standing under the laws of
the State of North Carolina and is duly qualified and authorized to transact business in the State
of New Mexico. Seller is duly authorized, qualified to do business and in good standing under all
applicable Laws of any Governmental Entity having jurisdiction over the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">business and operation of
the Purchased Assets to own its properties and conduct its business in the place and manner now
conducted. Except as set forth on <U>Schedule&nbsp;5.1</U>, the execution and delivery by Seller of
this Agreement and the documents described herein, the performance by Seller of its obligations
under this Agreement and the documents described herein and the consummation by Seller of the
transactions contemplated by this Agreement and the documents described herein
have been duly and validly authorized and approved by all necessary corporate actions on the
part of Seller and corporate actions on the part of the Manager, none of which actions have been
modified or rescinded and all of which actions remain in full force and effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.2 </B><U><B>Powers; Consents; Absence of Conflicts With Other Agreements, Etc</B></U>. The
execution, delivery and performance of this Agreement and the documents described herein by Seller
of the transactions contemplated by this Agreement and documents described herein, as applicable:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) are not in contravention or violation of the terms of the operating agreement
of Seller;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) except as set forth on <U>Schedule&nbsp;5.2</U>, do not require any material
Approval or Permit of, or filing or registration with, or other action by, any Governmental
Entity to be made or sought by Seller or any of its Affiliates; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) assuming the Approvals and Permits set forth on <U>Schedule&nbsp;5.2</U> are
obtained, will not conflict in any material respect with, or result in any violation of or
default under (with or without notice or lapse of time or both), or give rise to a right of
termination, cancellation, acceleration or augmentation of any obligation or to loss of a
material benefit under, or result in the creation of any material Encumbrance (other than
Permitted Encumbrances) upon any of the Purchased Assets under (i)&nbsp;any Assumed Contract or
(ii)&nbsp;any Law applicable to any of the Purchased Assets; <U>provided</U> that no
representation or warranty is given with respect to consents or approvals required to assign
any of the Assumed Contracts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.3 </B><U><B>Affiliates and Minority Interests</B></U>. <U>Schedule&nbsp;5.3</U> sets forth a true and
complete list of (i)&nbsp;any subsidiaries of Seller and (ii)&nbsp;any interest in another Person held by
Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.4 </B><U><B>No Outstanding Rights</B></U>. Except as set forth on <U>Schedule&nbsp;5.4</U>, there are
no outstanding rights (including any rights of first refusal or offer or rights of reverter),
options, or Contracts made on Seller&#146;s behalf giving any Person any current or future right to
require Seller or any of its Affiliates or, following the Closing Date, Buyer, to sell or transfer
to such Person or to any third party any material interest in any of the Purchased Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.5 </B><U><B>Binding Agreement</B></U>. This Agreement and all documents to which Seller will
become a party hereunder are and will constitute the valid and legally binding obligations of
Seller and are and will be enforceable against it in accordance with the respective terms hereof or
thereof, except as enforceability may be restricted, limited or delayed by applicable bankruptcy or
other Laws affecting creditors&#146; rights generally and except as enforceability may be subject to
general principles of equity.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.6 </B><U><B>Seller Financial Information</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Schedule&nbsp;5.6</U> hereto contains the following financial statements and
financial information (collectively, the &#147;<U>Historical Financial Information</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) unaudited balance sheet of the Hospital dated as of December&nbsp;31, 2010;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) unaudited statement of operations of the Hospital for the three (3)
month period ended on December&nbsp;31, 2010; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) audited balance sheets, statements of operations, and statements of
cash flows for the fiscal years ended September&nbsp;30, 2010 and 2009.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Except as disclosed on <U>Schedule&nbsp;5.6</U>, the financial statements included in the
Historical Financial Information have been prepared, and the Additional Financial Statements
have been and will be prepared, in accordance with GAAP in all material respects, applied on
a consistent basis throughout the periods indicated, and Seller has not changed any
accounting policy or methodology in determining the obsolescence of inventory throughout all
periods presented. Except as set forth on <U>Schedule&nbsp;5.6</U>, the balance sheets
contained in the Historical Financial Information present fairly, and the balance sheets in
the Additional Financial Statements present fairly and will present fairly, in all material
respects the financial condition of the Hospital as of the dates indicated thereon, and the
statements of operations contained in the Historical Financial Information present fairly,
and the statements of operations contained in the Additional Financial Statements present
fairly and will present fairly, in all material respects the results of operations of the
Hospital for the periods covered.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Except as set forth on <U>Schedule&nbsp;5.6</U> and except for (i)&nbsp;liabilities that
are disclosed in this Agreement, Contracts entered into in connection herewith and schedules
and exhibits hereto and thereto, and (ii)&nbsp;liabilities that were incurred after the Baseline
Balance Sheet Date in the ordinary course of business, as of the date hereof, there are no
material liabilities of any nature of Seller or any of its Affiliates relating to the
Hospital, the Purchased Assets or the Assumed Liabilities that are required in accordance
with GAAP to be disclosed on the financial statements of Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.7 </B><U><B>Permits and Approvals</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Set forth on <U>Schedule&nbsp;5.7</U> is a true and complete description of all
material Permits and Approvals currently issued or granted by a Governmental Entity and
owned or held by or issued to Seller in connection with the Purchased Assets, and such
Permits and Approvals constitute all material Permits and Approvals necessary for the
conduct of the business and operation of the Hospital as currently conducted and the use of
the Purchased Assets by Seller, all of which are in full force and effect.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Hospital is in compliance in all material respects with all Permits and
Approvals required by Law. There is not now pending nor, to the knowledge of Seller,
threatened in writing any action by or before any Governmental Entity to revoke, cancel,
rescind, modify or refuse to renew any of the Permits and Approvals, and all of the material
Permits and Approvals are and shall be in good standing now and as of the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.8 </B><U><B>Intellectual Property</B></U>. Except for Intellectual Property constituting Excluded
Assets:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Seller owns, is licensed to use or otherwise possesses all necessary rights to
use, all Intellectual Property used in the Hospital as of the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) To the knowledge of Seller, there is no unauthorized use, disclosure,
infringement or misappropriation of any Intellectual Property rights of Seller, any trade
secret material to Seller, or any Intellectual Property right of any third party to the
extent licensed by or through Seller, by any third party, including any employee or former
employee of Seller, relating in any way to any of the Purchased Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Except as set forth on <U>Schedule&nbsp;5.8</U>, neither Seller nor any of its
Affiliates has any patents, registered trademarks, registered service marks or registered
copyrights related to any of the Purchased Assets. Except as set forth on <U>Schedule
5.17</U>, neither Seller nor any of its Affiliates has been served with process in any suit,
action or proceeding which involves a claim of infringement of any patents, trademarks,
service marks, copyrights or violation of any trade secret or other proprietary right of any
third party related to any of the Purchased Assets. To the knowledge of Seller, the
business of the Hospital does not infringe any material Intellectual Property or other
material proprietary right of any third party. Neither Seller nor any Affiliate of Seller
has brought any action, suit or proceeding for infringement of Intellectual Property or
breach of any license or Contract involving Intellectual Property related to any of the
Purchased Assets against any third party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.9 </B><U><B>Medicare Participation/Accreditation</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Hospital is a &#147;provider&#148; with valid and current provider agreements and
with one or more provider numbers with the Government Programs. The Hospital is a
&#147;provider&#148; with valid and current provider agreements and with one or more provider numbers
with TRICARE or its successor programs. Except as set forth on <U>Schedule&nbsp;5.9</U>, the
Hospital is in compliance with the conditions of participation for the Government Programs
in all material respects and has received all Approvals or qualifications necessary for
capital reimbursement on the Purchased Assets. Except as set forth on <U>Schedule&nbsp;5.9</U>,
there is not pending, nor to the knowledge of Seller threatened in writing, any proceeding
or investigation under the Government Programs involving Seller or any of the Purchased
Assets. Except as disclosed on <U>Schedule&nbsp;5.9</U> and except for claims, actions and
appeals in the ordinary course of business, there are no material claims, actions or appeals
pending before any commission, board or agency, including any fiscal
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">intermediary or carrier, Governmental Entity or the Administrator of the Centers for
Medicare &#038; Medicaid Services, with respect to any Government Program cost reports or claims
filed on behalf of Seller with respect to the Hospital on or before the date of this
Agreement, or any disallowances by any commission, board or agency in connection with any
audit of such cost reports. Except as disclosed on <U>Schedule&nbsp;5.9</U> or except for those
audits and reviews in the ordinary course of business, no validation review or program
integrity review (including any recovery audit contract review) related to the Hospital, the
operation of the Hospital, or the consummation of the transactions contemplated by this
Agreement, has been conducted by any commission, board, agency or Governmental Entity in
connection with the Government Programs, and to the knowledge of Seller, no such reviews are
scheduled, pending or threatened against or affecting Seller with respect to the Hospital,
the operation of the Hospital, or the consummation of the transactions contemplated by this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Hospital is duly accredited, with no contingencies, by The Joint
Commission. Seller has provided Buyer copies of the most recent Joint Commission
accreditation survey report and deficiency list for the Hospital, if any, and each plan of
correction, if any.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) All billing practices of Seller with respect to the Hospital to all third party
payors, including the Medicare, Medicaid and CHAMPUS/TRICARE programs and private insurance
companies, have been in compliance in all material respects with all applicable laws,
regulations and policies of such third party payors and the Medicare, Medicaid and
CHAMPUS/TRICARE programs, and neither Seller nor the Hospital has billed or received any
payment or reimbursement in excess of amounts allowed by law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Neither Seller nor any of its officers, directors, or managing employees are
excluded from participation in the Medicare, Medicaid or CHAMPUS/TRICARE programs, nor to
Seller&#146;s knowledge is any such exclusion threatened in writing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Seller has registered with the QNet Exchange (&#147;<U>QNet</U>&#148;) as required by
The Centers for Medicare and Medicaid Services (&#147;<U>CMS</U>&#148;) under its Hospital Quality
Initiative Program (the &#147;<U>HQI Program</U>&#148;). Seller has in all material respects
submitted all quality data required under the HQI Program to CMS or its agent and all
quality data required under the ORYX Core Measure Performance Measurement System
(&#147;<U>ORYX</U>&#148;) to The Joint Commission for all calendar quarters concluded prior to the
date of this Agreement, except for any quarter for which the respective reporting deadlines
have not yet expired. All such submissions of quality data have been made in all material
respects in accordance with applicable reporting deadlines and in the form and manner
required by CMS and The Joint Commission, respectively. Seller has not received notice of
any reduction in reimbursement under the Medicare program resulting from its failure to
report quality data to CMS or its agent as required under the HQI Program. Seller has
provided Buyer with the HQI Program &#147;validation results&#148; for all calendar quarters concluded
prior to the date of this Agreement, except for any quarter for which the respective
reporting deadlines have not yet expired.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.10 </B><U><B>Regulatory Compliance</B></U>. Except as set forth on <U>Schedule&nbsp;5.10</U>, Seller
is in compliance in all material respects with all applicable statutes, rules, regulations and
requirements of Governmental Entities having jurisdiction over the Hospital and the Purchased
Assets and the business operation of the Hospital and the Purchased Assets. Seller has timely
filed all material forms, applications, reports, statements, data and other information required to
be filed with Governmental Entities. Neither Seller nor any of its employees, with respect to the
operation of the Hospital, have committed a violation of federal or state laws regulating health
care fraud, including but not limited to the federal Anti-Kickback Law, 42 U.S.C. &#167;1320a-7b, the
Stark I and II Laws, 42 U.S.C. &#167;1395nn, as amended, and to the knowledge of Seller, the False
Claims Act, 31 U.S.C. &#167;3729, <U>et</U> <U>seq</U>. To the knowledge of Seller, the Hospital is
in compliance in all material respects with the administrative simplification provisions required
under the Health Insurance Portability and Accountability Act of 1996 (&#147;HIPAA&#148;), including the
electronic data interchange regulations and the health care privacy regulations, as of the
applicable effective dates for such requirements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.11 </B><U><B>Scheduled Contracts</B></U>. Attached hereto as <U>Schedule&nbsp;5.11</U> is a list of
all Contracts to which Seller or any of Seller Affiliates is a party and which are material to the
operation of the Hospital (this representation shall not be breached if a De Minimis Contract is
not listed on <U>Schedule&nbsp;5.11</U>), including all provider network agreements, clinical
affiliation agreements, medical director agreements, consulting agreements, management services
agreements, professional services agreements, transfer agreements, recruitment agreements,
employment agreements, real estate lease agreements, personal property lease agreements, supply
agreements and software agreements, but excluding all Contracts with managed care organizations,
health maintenance organizations, insurers and similar third party payors, all of which are
Excluded Contracts. For each Contract listed on <U>Schedule&nbsp;5.11</U>, <U>Schedule&nbsp;5.11</U>
clearly identifies those Contracts that are Excluded Contracts and that will not be assumed by
Buyer. Contracts which are listed on <U>Schedule&nbsp;5.11</U> and not designated therein as an
Excluded Contract are referred to herein as the &#147;<U>Scheduled Contracts</U>.&#148; Each Scheduled
Contract (i)&nbsp;is valid and existing (or constitutes a month-to-month Contract under which goods or
services are being provided after the expiration of its original term), and Seller or the
applicable Affiliate of Seller has duly performed in all material respects its obligations under
each Scheduled Contract to which it is a party to the extent that such obligations to perform have
accrued and (ii)&nbsp;except for any breaches resulting from the failure to obtain the consent of the
counterparty thereto to the assignment of same to Buyer, no material breach or default, alleged
material breach or default, or event which would (with the passage of time, notice or both)
constitute a material breach or default under any Scheduled Contract by Seller or the applicable
Affiliate of Seller or, to the knowledge of Seller, and except as set forth on <U>Schedule
5.11</U>, any other party or obligor with respect thereto, has occurred.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.12 </B><U><B>Encumbrances; Real Property</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) There are no Encumbrances (other than Permitted Encumbrances) on the Purchased
Assets that were created by, through or under Seller or any Affiliate of Seller. Seller
owns, and will convey good and marketable fee simple absolute title in the Owned Real
Property, and all buildings and improvements located thereon, to Buyer free and clear of all
Encumbrances except for Permitted Encumbrances. Seller agrees that title to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">the Real Property shall not be altered between the date of this Agreement and Closing
in any material respect, except to the extent not restricted by Sections&nbsp;7.2 and 7.3.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) (i)&nbsp;All buildings and improvements located on the Real Property conform in all
material respects with all applicable zoning regulations and building codes; (ii)&nbsp;all of the
Real Property is serviced by all necessary utilities, including water, sewage, electricity
and telephone, and Seller is not aware of any material inadequacies with respect to such
utilities; (iii)&nbsp;to the knowledge of Seller, none of the buildings or improvements on the
Real Property is located in a flood hazard area; and (iv)&nbsp;all of the buildings and
improvements located on the Real Property are accessible by public roads and, to the
knowledge of the Seller, no fact or condition exists that would result in the termination of
the current access from any building or improvement to any presently existing highways and
roads adjoining or situated on the Real Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Real Property comprises all of the real property owned or leased by Seller
that is associated with or employed in the operation of the Hospital.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.13 </B><U><B>Personal Property</B></U>. Seller presently owns and will hold on the Closing Date
good title to all tangible personal property assets and valid title to all intangible assets
included in the Purchased Assets free and clear of all Encumbrances, except Permitted Encumbrances
and rights of owners under Assumed Contracts or under leases or licenses of assets leased or
licensed in the ordinary course of business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.14 </B><U><B>Insurance</B></U>. <U>Schedule&nbsp;5.14</U> sets forth a true and complete list of all
insurance policies or self insurance funds maintained by Seller as of the date of this Agreement
covering the ownership and operation of the Purchased Assets or the Hospital, indicating the types
of insurance, policy numbers, terms, identity of insurers and amounts and coverages (including
applicable deductibles). All of such policies are now and will be until the Closing in full force
and effect on an occurrence basis (with the exception of the Hospital&#146;s professional liability
insurance, pollution liability insurance, employment practices liability insurance, directors and
officers liability insurance and fiduciary liability insurance, all of which are on a claims made
basis, and crime liability insurance which is on a discovery basis) with no premium arrearages.
Such policies of insurance shall not be assigned to Buyer as part of the Purchased Assets and Buyer
acknowledges that all of the coverages listed on <U>Schedule&nbsp;5.14</U> with respect to the
Purchased Assets will cease on the Closing Date. Seller has in all material respects given in a
timely manner to its insurers all notices required to be given under its insurance policies with
respect to all of the claims and actions covered by insurance, and no insurer has denied coverage
of any such claims or actions. Seller has not (a)&nbsp;received any notice or other communication from
any such insurance company canceling or materially amending any of such insurance policies, and no
such cancellation or amendment is threatened in writing or (b)&nbsp;failed to give any required notice
or present any claim which is still outstanding under any of such policies with respect to the
Hospital or any of the Purchased Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.15 </B><U><B>Employee Benefit Plans</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Schedule&nbsp;5.15</U> contains a true and complete list of all the following
agreements, plans or other Contracts, covering any employee of the Hospital, which are
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">presently in effect: (i)&nbsp;employee benefit plans within the meaning of Section&nbsp;3(3) of
ERISA, and (ii)&nbsp;any other employee benefit plan, program, policy, or arrangement, whether
written or unwritten, formal or informal, which Seller currently sponsors, or to which
Seller has any outstanding present or future obligations to contribute or other liability,
whether voluntary, contingent or otherwise (collectively, the &#147;<U>Plans</U>&#148;). None of the
Plans provide any post-employment medical or similar benefits except for COBRA coverage
required by federal Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Purchased Assets are not, and Seller does not reasonably expect them to
become, subject to an Encumbrance imposed under the Code or under Title I or Title IV of
ERISA including liens arising by virtue of Seller being a member of an ERISA Controlled
Group.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Neither Seller nor any member of Seller&#146;s ERISA Controlled Group has sponsored,
contributed to or had any &#147;obligation to contribute&#148; (as defined in ERISA Section&nbsp;4212) to
any &#147;multiemployer plan&#148; (as defined in ERISA Section&nbsp;4001(a)(3) or 3(37)(A)) on or after
September&nbsp;26, 1980, on behalf of any employees of the Hospital.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Neither Seller nor any member of Seller&#146;s ERISA Controlled Group has at any
time sponsored or contributed to any &#147;single employer plan&#148; (as defined in ERISA Section
4001(a)(14)) to which at least two or more of the &#147;contributing sponsors&#148; (as defined in
ERISA Section&nbsp;4001(a)(13)) are not members of the same ERISA Controlled Group.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) There have been no non-exempt prohibited transactions with respect to any Plan.
Neither Seller nor any ERISA Affiliate, nor to Seller&#146;s knowledge, any other Person for
which Buyer or any of its Affiliates could have any liability, has breached any fiduciary
duty with respect to any Plan for which Buyer or any of its Affiliates could have any
liability. Except as set forth on <U>Schedule&nbsp;5.15</U>, there are no material actions,
audits or claims pending or, to Seller&#146;s knowledge, threatened in writing against Seller
with respect to Seller&#146;s maintenance of the Plans, other than routine claims for benefits.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Seller and each member of Seller&#146;s ERISA Controlled Group have complied in all
material respects with the continuation coverage requirements of Section&nbsp;1001 of the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, ERISA Sections&nbsp;601
through 608 and Section&nbsp;5000 of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) All of Seller&#146;s Plans that are intended to satisfy Section 401(a) of the Code
(&#147;<U>Retirement Plans</U>&#148;) from which assets may be involved in a &#147;direct rollover&#148; (as
defined in Section&nbsp;401(a)(31) of the Code) to an employee benefit plan maintained by Buyer
have complied with the requirements of Section 401(a) of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) All contributions, including salary deferrals, required to be made under the
terms of any of the Plans as of the date of this Agreement have been timely made or, if not
yet due, have been (and will be) properly reflected in the Historical Financial Information
or the Additional Financial Statements, as applicable.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.16 </B><U><B>Hospital Employees and Employee Relations</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Except as set forth on <U>Schedule&nbsp;5.16(a)</U>, (i)&nbsp;there is no pending or, to
Seller&#146;s knowledge, threatened in writing employee strike, work stoppage or labor dispute,
(ii)&nbsp;to Seller&#146;s knowledge, no union representation question exists with respect to any
Hospital Employees, no demand has been made for recognition by a labor organization by or
with respect to any Hospital Employees, no union organizing activities by or with respect to
any Hospital Employees are taking place, and none of the Hospital Employees is represented
by any labor union or organization, (iii)&nbsp;no collective bargaining agreement exists or is
currently being negotiated by Seller or any Seller Affiliate, and (iv)&nbsp;there is no unfair
labor practice claim against Seller or any Seller Affiliate before the National Labor
Relations Board, or any strike, dispute, slowdown, or stoppage pending or, to Seller&#146;s
knowledge, threatened in writing against or involving the Hospital and none has occurred.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Schedule&nbsp;5.16(b)</U> sets forth a list of all of the employees of Seller
and each other Seller Affiliate who works primarily or exclusively for the benefit of the
business conducted at the Hospital (the &#147;<U>Hospital Employees</U>&#148;) as of the date of such
Schedule and the following information for each Hospital Employee: current salary or wage
rate, accrued paid time off, periods of service, date of hire, department and job title or
other summary of the responsibilities as well as an indication as to whether such Hospital
Employee is part-time, full-time or on a leave of absence and the type of leave;
<U>provided</U>, that salary and wage rate information may be excluded from <U>Schedule
5.16(b)</U> so long as Seller delivers a true and correct schedule of such salary and wage
rate information to Buyer concurrently with the delivery of <U>Schedule&nbsp;5.16(b)</U> to
Buyer. Seller is in compliance in all material respects with all applicable Laws respecting
labor, employment, fair employment practices, terms and conditions of employment, workers&#146;
compensation, occupational safety, plant closings, and wages and hours with respect to the
Hospital Employees. The Hospital has properly classified individuals providing services as
independent contractors or Hospital Employees, as the case may be. Each of the Hospital
Employees has properly completed an I-9 form reflecting the Hospital Employee&#146;s citizenship
or authorization to work in the United States, and to Seller&#146;s knowledge, the statements
contained in and the supporting documents presented for each of those forms is valid and
accurate in all material respects.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.17 </B><U><B>Litigation or Proceedings</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Schedule&nbsp;5.17</U> contains an accurate list and summary description of all
litigation and proceedings which are currently pending with respect to the Hospital, the
Purchased Assets or the business conducted thereon to which Seller is a party. Except to
the extent set forth on <U>Schedule&nbsp;5.17</U>, there are no material claims, actions, suits,
audits, compliance reports or information requests, proceedings or investigations pending,
or to the knowledge of Seller, threatened in writing against or affecting Seller or the
Purchased Assets or the business conducted thereon.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Other than as set forth on <U>Schedule&nbsp;5.17</U>, Seller is not subject to any
outstanding judgment, order or decree with respect to the Purchased Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) There is no claim, action, suit, proceeding or investigation pending or, to the
knowledge of Seller, threatened in writing against or affecting Seller that has or would
reasonably be expected to have a material adverse effect on Seller&#146;s ability to perform this
Agreement or any aspect of the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.18 </B><U><B>Tax Matters</B></U>. Except as set forth on <U>Schedule&nbsp;5.18</U>:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All federal, state, county and local income, franchise, margin, payroll,
withholding, property, sales, use and all other taxes, penalties, interest and any other
statutory additions (&#147;<U>Taxes</U>&#148;) due from Seller with respect to the Purchased Assets
have been timely paid. Seller has timely filed all material Tax returns required to be
filed by it with respect to the Purchased Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) No deficiencies for any of such material Taxes have been asserted or, to the
knowledge of Seller, threatened in writing, and no audit on any such returns is currently
under way or, to the knowledge of Seller, threatened in writing. There are no outstanding
agreements by Seller for the extension of time for the assessment of any such Taxes. Seller
has not taken and will not take any action in respect of any federal, state or local Taxes
(including, without limitation, any withholdings required to be made in respect of
employees) which may have a material adverse impact upon the Hospital or the Purchased
Assets as of or subsequent to Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) There are no Tax liens on any of the Purchased Assets other than liens for
Taxes not yet due.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Seller is a partnership for federal and state income tax purposes but is not
and has not been a party to any other joint venture, partnership or other arrangement or
contract that could be treated as a partnership for federal and state income Tax purposes.
Seller has no liability for unpaid Taxes of any Person as a former member of an affiliated
group or as a transferee or successor, and is not a party to any tax allocation or sharing
agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.19 </B><U><B>Environmental Matters</B></U>. Except as set forth on <U>Schedule&nbsp;5.19</U> or in
any environmental report listed therein:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Seller is in material compliance with, and the Real Property and all
improvements on the Real Property are in material compliance with, all Environmental Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) There are no pending or, to the knowledge of Seller, threatened in writing
actions, suits, orders, claims, legal proceedings or other proceedings based on any
complaint, order, directive, citation, notice of responsibility, notice of potential
responsibility, or information request from any Governmental Entity or any other Person
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">and Seller has no knowledge of any facts which would reasonably be expected to form the
basis for any such actions or notices arising out of or attributable to any Environmental
Condition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Seller has been duly issued, and currently has and will maintain through the
Closing Date, all material Approvals and Permits required under any Environmental Law with
respect to the Hospital. A true and complete list of such Permits, all of which are valid
and in full force and effect, is set forth in <U>Schedule&nbsp;5.19</U>. Seller is in material
compliance (with respect to the Hospital) with and the Real Property and all improvements on
the Real Property are in material compliance with, all Approvals and Permits. Except in
accordance with such Approvals and Permits, there has been no release of material regulated
by such Approvals and Permits at, on, under, or from the Real Property in violation of
Environmental Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Seller has operated at the Real Property, and to the Seller&#146;s knowledge, the
Real Property contains no underground improvements, including treatment or storage tanks, or
underground piping associated with such tanks, used currently or in the past for the
management of Hazardous Materials, and Seller has not used any portion of the Real Property
as a dump or landfill.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Seller will promptly furnish to Buyer written notice of any material
Environmental Condition or of any actions or notices described in this Section&nbsp;5.19.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Except to the extent permitted under Environmental Laws, neither PCBs, lead
paint, nor asbestos-containing materials are present on or in the Real Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) No Encumbrance in favor of any Person relating to or in connection with any
claim under any Environmental Law has been filed or has attached to the Real Property, other
than Permitted Encumbrances.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The representations set forth in this Section are the sole representations of the Seller with
respect to environmental matters, Environmental Conditions, Hazardous Materials and compliance with
Environmental Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.20 </B><U><B>Absence of Changes</B></U>. Except as set forth in <U>Schedule&nbsp;5.20</U>, since the
Baseline Balance Sheet Date, there has not been any transaction or occurrence in which Seller or
any Seller Affiliate, in connection with the Hospital and Purchased Assets, has:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) suffered any material damage, destruction or loss with respect to or affecting
any of the Purchased Assets;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) sold, transferred or otherwise disposed of any of the Purchased Assets which is
material to the operation of the Hospital, except in the ordinary course of business;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) granted or incurred any obligation for any increase in the compensation of any
employee who is employed at the Hospital (including any increase pursuant to any Plans or
other commitment), except in the ordinary course of business, or entered into any
employment, severance or similar agreement with any member, manager, employee or agent;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) changed its methods of accounting in effect on the Baseline Balance Sheet Date,
except as required by changes in GAAP or regulatory accounting principles (which shall be
set forth in <U>Schedule&nbsp;5.20</U>);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) experienced any material change in the composition of the medical staff of the
Hospital, other than normal turnover occurring in the ordinary course of business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) materially changed the rates charged by the Hospital for its services, other
than those made in the ordinary course of business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) experienced any Material Adverse Effect or any fact or condition likely to have
or which could be expected to have a Material Adverse Effect; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) agreed, so as to legally bind Buyer or affect the Purchased Assets, whether in
writing or otherwise, to take any of the actions set forth in this Section&nbsp;5.20 and not
otherwise permitted by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.21 </B><U><B>Medical Staff Matters</B></U>. Seller has delivered to Buyer correct and complete
copies of the bylaws and rules and regulations of the medical staff of the Hospital, as well as a
list of all current members of the medical staff. Seller has disclosed to Buyer in all material
respects (i)&nbsp;all adverse actions with respect to any medical staff members of the Hospital or any
applicant thereto for which a medical staff member or applicant has requested a judicial review
hearing which has not been scheduled or has been scheduled but has not been completed, (ii)&nbsp;any
pending or, to the knowledge of Seller, threatened in writing disputes with applicants, staff
members, or health professional affiliates, and (iii)&nbsp;any unexpired appeal periods in respect of
any medical staff member or applicant against whom an adverse action has been taken. Any
disclosures have been and will be made in such a manner as to protect the confidentiality of the
Persons involved in the matters described thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.22 </B><U><B>Sufficiency of Purchased Assets</B></U>. Except for the Excluded Assets and for the
services to be provided by Seller and its Affiliates pursuant to the Transition Services Agreement,
the Purchased Assets constitute, in the aggregate, all the assets and property used by Seller in
connection with the operation of the Hospital as currently conducted in all material respects.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.23 </B><U><B>Experimental Procedures</B></U>. During the past three (3)&nbsp;years, Seller has not
performed nor permitted the performance of any experimental or research procedures or studies
involving patients in the Hospital except, in all material respects, to the extent authorized by
and conducted in accordance with the procedures of an Institutional Review Board responsible for
oversight of research at the Hospital.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.24 </B><U><B>Supplies</B></U>. Except to the extent of reserves reflected in Net Working Capital,
all of the Inventory is substantially of a quality and quantity usable and salable in the ordinary
course of business of the Hospital to the extent reflected in the Interim NWC Calculation.
Inventory is carried at the lower of cost or market, on an average cost basis and is properly
stated in the Historical Financial Information. The Inventory levels are based on past practices
of Seller at the Hospital in all material respects.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.25 </B><U><B>Third Party Payor Cost Reports</B></U>. Seller has duly filed all required cost
reports for all the fiscal years through and including the fiscal year ended September&nbsp;30, 2009.
Seller intends to file the Hospital&#146;s cost report for the fiscal year ended on September&nbsp;30, 2010
within the time period required by Law. Except as disclosed on <U>Schedule&nbsp;5.25</U>, all of such
cost reports accurately reflect in all material respects the information required to be included
thereon and such cost reports do not claim and neither the Hospital nor Seller has received
reimbursement in any amount in excess of the amounts provided by law or any applicable agreement.
<U>Schedule&nbsp;5.25</U> indicates which of such cost reports have not been audited and finally
settled and a brief description of any and all notices of program reimbursement, proposed or
pending audit adjustments, disallowances, appeals of disallowances, and any and all other
unresolved claims or disputes in respect of such cost reports.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.26 </B><U><B>Compliance Program</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Seller has made available to Buyer a copy of its current compliance program
materials, including without limitation, all program descriptions, compliance officer and
committee descriptions, ethics and risk area policy materials, training and education
materials, auditing and monitoring protocols, reporting mechanisms, and disciplinary
policies. For purposes of this Agreement, the term &#147;compliance program&#148; refers to provider
programs of the type described in the compliance guidance published by the Office of
Inspector General of the Department of Health and Human Services.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Except as set forth in a writing delivered by Seller to Buyer which
specifically makes reference to this Section&nbsp;5.26 or to the extent set forth on <U>Schedule
5.26</U>, Seller: (i)&nbsp;is not a party to a Corporate Integrity Agreement with the Office of
Inspector General of the Department of Health and Human Services; (ii)&nbsp;has no reporting
obligations pursuant to any Settlement Agreement entered into with any governmental entity;
and (iii)&nbsp;to its knowledge, has not been a defendant in any <I>qui tam</I>/False Claims Act
litigation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Except as set forth on <U>Schedule&nbsp;5.26</U>, since January&nbsp;1, 2007 Seller (i)
to the best of Seller&#146;s knowledge, has not been the subject of any government payer program
investigation conducted by any federal or state enforcement agency; (ii)&nbsp;has not been served
with or received any search warrant, subpoena, civil investigative demand, contact letter,
or telephone or personal contact by or from any federal or state enforcement agency which
may be reasonably anticipated to give rise to a government investigation; and (iii)&nbsp;has not
received any complaints from employees, independent contractors, vendors, physicians, or any
other person that, after investigation or review conducted by
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Seller, would indicate that Seller has in any material respects violated any law or
regulation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.27 </B><U><B>Statements True and Correct</B></U>. This Agreement and the Schedules prepared by
Seller do not include, as of the date hereof, any untrue statement of a material fact or omit to
state any material fact necessary to make the statements made in this Agreement with respect to
Seller and the Purchased Assets not misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>5.28 </B><U><B>No Other Representations and Warranties</B></U>. EXCEPT FOR THE REPRESENTATIONS AND
WARRANTIES CONTAINED IN THIS ARTICLE 5 (INCLUDING THE SCHEDULES), SELLER MAKES NO EXPRESS OR
IMPLIED REPRESENTATION OR WARRANTY, AND SELLER HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY
WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE CONSUMMATION OF THE
TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 6</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>COVENANTS OF BUYER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>6.1 </B><U><B>Notification of Certain Matters</B></U>. At any time from the date of this Agreement
to the Closing Date, Buyer shall give prompt written notice to Seller of (i)&nbsp;the occurrence, or
failure to occur, of any event that has caused any representation or warranty of Buyer contained in
this Agreement to be untrue in any material respect and (ii)&nbsp;any failure of Buyer to comply with or
satisfy, in any material respect, any covenant, condition or agreement to be complied with or
satisfied by it under this Agreement. Such notice shall provide a reasonably detailed description
of the relevant circumstances.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>6.2 </B><U><B>HSR Act Filings</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Within five (5)&nbsp;business days following the date hereof, Buyer shall make such
premerger filings with the FTC and the Justice Department as may be required under the HSR
Act, concerning the transactions contemplated by this Agreement. From the date of such
filing until the Closing Date, Buyer shall file all reports or other documents required or
requested by the FTC or the Justice Department under the HSR Act or otherwise and will
comply promptly with any requests by the FTC or the Justice Department for additional
information concerning the transactions described herein, so that the waiting period
specified in the HSR Act will expire as soon as reasonably possible after the execution and
delivery of this Agreement. Buyer agrees to take all commercially reasonable actions
necessary to insure that the waiting period imposed under the HSR Act terminates or expires
prior to thirty (30)&nbsp;days after the date of making such premerger filings. Without limiting
the foregoing, Buyer agrees to use commercially reasonable efforts to cooperate with Seller
and oppose any preliminary injunction sought by any Governmental Entity preventing the
consummation of the transactions contemplated by this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Buyer shall cause its counsel to furnish to Seller such necessary information
and reasonable assistance as Seller may reasonably request in connection with its
preparation of necessary filings or submissions under the provisions of the HSR Act. Buyer
will cause its counsel to deliver to Seller&#146;s counsel copies of all correspondence, filings
or written communications by Buyer or its Affiliates with any Governmental Entity or staff
members thereof, with respect to the transactions contemplated by this Agreement, except for
(i)&nbsp;information that is not pertinent to such filing or submission or that is not
customarily exchanged between parties making such a filing or their counsel, including
documents filed pursuant to Item 4(c) of the Hart-Scott-Rodino Notification and Report Form
or communications regarding such documents or (ii)&nbsp;information submitted in response to any
request for additional information or documents pursuant to the HSR Act which reveal the
negotiating objectives or strategies or purchase price expectations of Buyer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Buyer shall pay all application fees required in connection with any filings
required under the HSR Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>6.3 </B><U><B>Approvals</B></U>. Between the date of this Agreement and the Closing Date, Buyer
will (i)&nbsp;take all reasonable steps to obtain, as promptly as practicable, all Approvals and Permits
of any Governmental Entities required of either party to consummate the transactions contemplated
by this Agreement and Seller will reasonably cooperate with Buyer in those efforts and (ii)&nbsp;provide
such other information and communications to any Governmental Entity as may be reasonably
requested. Seller understands and acknowledges that it is the intent of Buyer to cause the
operations, hospital licensure and Medicare certification of Lovelace Medical Center, a general
acute care hospital that is owned and operated by Buyer (&#147;<U>LMC</U>&#148;), to be expanded to
encompass and include the Purchased Assets. To this end, Buyer and its Affiliates will also use
commercially reasonable efforts to obtain all necessary Approvals of Governmental Entities to
accomplish such expansion of the operations, hospital licensure and Medicare certification of LMC
to encompass and include the Purchased Assets. Notwithstanding the foregoing or anything in Section
6.3 to the contrary, Buyer acknowledges that Seller shall not be required to make any CMS Form&nbsp;855
filings as a result of the Transaction until ten (10)&nbsp;days after the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>6.4 </B><U><B>Survey</B></U>. Between the date of this Agreement and the Closing Date, Buyer will
obtain a current as-built survey of the Owned Real Property (the &#147;<U>Survey</U>&#148;). The Survey
shall meet the requirements of ALTA/ASCM survey and otherwise be in form and detail reasonably
satisfactory to Buyer. The Survey shall be certified to Buyer, Seller and the Title Company. The
cost of the Survey shall be paid by Buyer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>6.5 </B><U><B>Environmental Survey</B></U>. Between the date of this Agreement and the Closing
Date, Buyer shall retain a nationally recognized environmental consultant reasonably acceptable to
Seller to perform Phase I environmental assessments of the Owned Real Property in accordance with
the U.S. Environmental Protection Agency Standards and Practices for All Appropriate Inquiries as
required under Section&nbsp;101(35)(B) of the Comprehensive Environmental Response, Compensation, and
Liability Act and referenced in 40 CFR Part&nbsp;312, and the ASTM E 1527-05 &#147;Standard Practice for
Environmental Site Assessments&#148; (the &#147;<U>Phase I</U>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Assessment</U>&#148;). Buyer shall provide to Seller a copy of the final report issued by
Buyer&#146;s environmental consultant in connection with the Phase I Assessment. The cost of the Phase
I Assessment shall be paid by Buyer.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 7</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>COVENANTS OF SELLER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.1 </B><U><B>Information</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Between the date of this Agreement and the Closing Date, to the extent
permitted by Law, Seller shall afford to the authorized representatives and agents of Buyer
reasonable access to and the right to inspect the plants, properties, books and records of
Seller relating to the Purchased Assets, and will furnish Buyer with such additional
financial and operating data and other information as to the business and properties of
Seller relating to the Purchased Assets as Buyer may from time to time reasonably request;
<U>provided</U>, <U>however</U>, that Buyer may not conduct invasive environmental, health
or safety investigations upon the Real Property or at the Hospital or of the Purchased
Assets, including any sampling or testing of soils, surface water, groundwater, ambient air,
or improvements at, on or under Real Property, or sampling or testing of the Hospital or the
Purchased Assets, without Seller&#146;s prior written consent. The right of access and
inspection of Buyer shall be made in such a manner as not to interfere unreasonably with the
operation of the Hospital or the Purchased Assets. In this regard, Buyer agrees that such
inspection shall not take place, and no employees or other personnel at the Hospital shall
be contacted by the representatives of Buyer, without first coordinating such contact or
inspection with a representative of Navigant Capital Advisors, LLC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding the foregoing, Buyer understands that (i)&nbsp;Seller will
reasonably establish procedures in order to protect documents and information deemed by
Seller in good faith to be market sensitive or competitive in nature, including without
limitation pricing information related to managed care contracts, (ii)&nbsp;litigation and other
materials (including internal/external legal audit letters, PRO information, National
Practitioner Data Bank reports, quality review information and other physician specific
confidential information and information subject to confidentiality requirements of Law)
that are deemed privileged or confidential by Seller will not be made available to Buyer,
and (iii)&nbsp;Seller shall not be obligated to generate or produce information in any prescribed
format not customarily produced by Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.2 </B><U><B>Operations</B></U>. From the date hereof until the Closing Date, except as set forth
in <U>Schedule&nbsp;7.2</U>, Seller shall with respect to the Purchased Assets (unless prior written
consent of Buyer is received which will not be unreasonably withheld) use its commercially
reasonable efforts to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) carry on its business related to the Purchased Assets in substantially the same
manner as presently conducted and not make any material change in personnel,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">operations, finance, accounting policies, or real or personal property pertaining to
the Hospital;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) maintain the Hospital and all parts thereof in accordance with Seller&#146;s past
practices in all material respects;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) perform all of its material obligations under agreements relating to or
affecting the Hospital or the Purchased Assets;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) keep in full force and effect present insurance policies or other comparable
insurance on the Purchased Assets;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) use commercially reasonable efforts to maintain and preserve its business
organizations intact, retain its present employees at the Hospital and maintain its
relationships with physicians, suppliers, customers, and others having business relations
with the Hospital;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) permit and allow reasonable access by Buyer to make offers of post-Closing
employment to Seller&#146;s personnel and to establish relationships with physicians, medical
staff and others having business relations with Seller; <U>provided</U> that Buyer shall
have complied with the terms of Section&nbsp;7.1 in connection with such access; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) maintain all material Approvals and Permits relating to the Hospital, Purchased
Assets and Assumed Liabilities in good standing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.3 </B><U><B>Negative Covenants</B></U>. From the date hereof until the Closing Date, except as
set forth in <U>Schedule&nbsp;7.3</U>, Seller shall not, without the prior written consent of Buyer
(which will not be unreasonably withheld):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) materially amend or terminate any of the Contracts which are material to the
operation of the Hospital, enter into any material contract or commitment, or incur or agree
to incur any material liability, except as provided herein or, in all material respects, in
the ordinary course of business; <U>provided</U> that Buyer&#146;s consent shall not be required
to the extent that such contract or commitment is material to the continued operation of the
Hospital in the manner in which the Hospital was operated as of the date of this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) enter into any contract or commitment with physicians or other referral
sources; <U>provided</U> that Buyer&#146;s consent shall not be required to the extent that such
contract or commitment is material to the continued operation of the Hospital in the manner
in which the Hospital was operated as of the date of this Agreement and such contract
terminates or is terminated without penalty upon no more than ninety (90)&nbsp;days written
notice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) increase compensation payable or to become payable or make any bonus payment to
or otherwise enter into one or more bonus agreements with any Hospital
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Employee, except in the ordinary course of business in accordance with existing
personnel policies;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) acquire (whether by purchase or lease) or sell, assign, lease, or otherwise
transfer or dispose of any material property, plant, or equipment except in the ordinary
course of business with, in the case of a transfer or disposition, comparable replacement
thereof if such replacement is required in order to operate the Hospital in the manner it
was operated as of the date of this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) purchase capital assets or incur costs in respect of construction-in-progress
in excess of Fifty Thousand Dollars ($50,000) in the aggregate;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) take any material action outside the ordinary course of business of the
Hospital or its related ancillary services; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) enter into any agreement which could be reasonably expected to have a Material
Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.4 </B><U><B>Notification of Certain Matters</B></U>. At any time from the date of this Agreement
to the Closing Date, Seller shall give prompt written notice to Buyer of (i)&nbsp;the occurrence, or
failure to occur, of any event that has caused any representation or warranty of Seller contained
in this Agreement to be untrue in any material respect and (ii)&nbsp;any failure of Seller to comply
with or satisfy, in any material respect, any covenant, condition or agreement to be complied with
or satisfied by it under this Agreement. Such notice shall provide a reasonably detailed
description of the relevant circumstances.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.5 </B><U><B>HSR Act Filings</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Within five (5)&nbsp;business days following the date hereof, Seller shall make such
premerger filings with the FTC and the Justice Department as may be required under the HSR
Act, concerning the transactions contemplated by this Agreement. From the date of such
filing until the Closing Date, Seller shall file all reports or other documents required or
requested by the FTC or the Justice Department under the HSR Act or otherwise and will
comply promptly with any requests by the FTC or the Justice Department for additional
information concerning the transactions described herein, so that the waiting period
specified in the HSR Act will expire as soon as reasonably possible after the execution and
delivery of this Agreement. Seller agrees to take all commercially reasonable actions
necessary to insure that the waiting period imposed under the HSR Act terminates or expires
prior to thirty (30)&nbsp;days after the date of making such premerger filings. Without limiting
the foregoing, Seller agrees to use commercially reasonable efforts to cooperate with Buyer
and oppose any preliminary injunction sought by any Governmental Entity preventing the
consummation of the transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Seller shall cause its counsel to furnish Buyer such necessary information and
reasonable assistance as Buyer may reasonably request in connection with its
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">preparation of necessary filings or submissions under the provisions of the HSR Act.
Seller will cause its counsel to deliver to counsel for Buyer copies of all correspondence,
filings or written communications by Seller or its Affiliates with any Governmental Entity
or staff members thereof, with respect to the transactions contemplated by this Agreement,
except for (i)&nbsp;information that is not pertinent to such filing or submission or that is not
customarily exchanged between parties making such a filing or their counsel, including
documents filed pursuant to Item 4(c) of the Hart-Scott-Rodino Notification and Report Form
or communications regarding such documents or (ii)&nbsp;information submitted in response to any
request for additional information or documents pursuant to the HSR Act which reveal
Seller&#146;s negotiating objectives or strategies or purchase price expectations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.6 </B><U><B>Additional Financial Information</B></U>. Within fifteen (15)&nbsp;days following the end
of each calendar month prior to the Closing Date, Seller will deliver to Buyer copies of the
unaudited balance sheet and the related unaudited statement of operations relating to the Hospital
for each month then ended (all such financial statements are referred to herein as the
&#147;<U>Additional Financial Statements</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.7 </B><U><B>No-Shop Clause</B></U>. From and after the date of the execution and delivery of this
Agreement by Seller until the earlier of Closing or the termination of this Agreement, Seller shall
not (and will not permit any Affiliate or any other Person acting for or on behalf of Seller or any
of its Affiliates), without the prior written consent of Buyer (i)&nbsp;offer for lease or sale its
assets (or any material portion thereof) or any ownership interest in any entity owning any of the
Purchased Assets; (ii)&nbsp;solicit offers to lease or buy all or any material portion of its assets or
any ownership interest in any entity owning any of the Purchased Assets; (iii)&nbsp;hold discussions
with any party (other than Buyer) looking toward such an offer or solicitation or looking toward a
merger or consolidation of Seller; (iv)&nbsp;enter into any agreement with any party (other than Buyer)
with respect to the lease, sale or other disposition of its assets (or any material portion
thereof) or any ownership interest Seller or with respect to any merger, consolidation or similar
transaction involving Seller; or (v)&nbsp;furnish or cause to be furnished any information with respect
to Seller or its assets to any Person that Seller or such Affiliate or any such Person acting for
or on their behalf knows or has reason to believe is in the process of considering any such
acquisition, merger, consolidation, combination or reorganization, <U>provided</U> the foregoing
shall not prevent MedCath Corporation or Persons acting for or on its behalf from including any
information it deems required by Law in any of its filings with the Securities and Exchange
Commission. Nothing in this Section&nbsp;7.7, however, shall apply to or otherwise restrict any
actions, negotiations or agreements in respect of any transaction involving a sale of equity,
merger, combination, a sale of all or substantially all of its assets or similar transaction
involving MedCath Corporation or its Affiliates and any other Person, so long as such transaction
does not affect the obligations and duties of Seller or rights of Buyer under this Agreement;
provided however, the obligations of MedCath Corporation and Seller set forth in this Section&nbsp;7.7
are subject in all respects to the exercise of the fiduciary duties, or other comparable duties, of
the board of directors of MedCath Corporation to its shareholders and to the terms of Sections&nbsp;8.5
and 11.16 of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.8 </B><U><B>Title Policy</B></U>. Seller shall cooperate with Buyer in its efforts to cause the
Title Company to issue and deliver to Buyer the Title Commitment to issue an ALTA owner&#146;s policy of
title insurance, Form&nbsp;B, with extended coverage, for the Owned Real Property, together with
improvements, buildings and fixtures thereon, in amounts equal to the reasonable value assigned to
such Owned Real Property by the parties and in the customary form prescribed for use in the State
of New Mexico, but with any mandatory arbitration provision deleted therefrom (unless such deletion
would not be customary under local practice). The Title Commitment will provide for the issuance
of a title insurance policy (or policies) to Buyer, as of Closing, which policy (or policies) shall
insure good and marketable fee simple absolute title to Owned Real Property subject only to
Permitted Encumbrances, and shall contain such endorsements thereto as Buyer may reasonably require
in connection with its review of the Title Commitment and the Survey. Seller agrees to deliver any
information as may be reasonably required by the Title Company under the requirements section of
the Title Commitment or otherwise in connection with the issuance of a title insurance policy to
Buyer. Seller also agrees to provide an affidavit of title and/or such other information as the
Title Company may reasonably require in order for the Title Company to delete the so-called &#147;gap&#148;
exception (i.e., the period of time between the effective date of the Title Company&#146;s last
bringdown of title to such Owned Real Property and the Closing Date), the parties in possession
exception and the mechanics&#146; and materialmen&#146;s liens exception, and Buyer and Seller shall
cooperate in good faith and use commercially reasonable efforts to cause the Title Company to
delete all other standard exceptions from the final title insurance policy. The premium cost
related to the standard owner&#146;s title insurance policy shall be paid by Seller and the costs
associated with any extended owner&#146;s title insurance policy (including all endorsements) shall be
paid by Buyer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.9 </B><U><B>Provider Agreements</B></U>. In accordance with the requirements of applicable Law,
Seller shall notify the appropriate Governmental Entities of its intent to terminate as of the
Closing Date Seller&#146;s provider agreements related to the Government Programs and TRICARE. Seller
shall take all other required steps to terminate its participation in the Government Programs and
TRICARE effective as of the Closing Date, including, but not limited to, terminating provider
numbers and national provider identifier (NPI)&nbsp;numbers related to the Hospital. Notwithstanding the
foregoing or anything in Section&nbsp;7.9 to the contrary, Buyer acknowledges that Seller shall not be
required to make any CMS Form&nbsp;855 filings as a result of the Transaction until ten (10)&nbsp;days after
the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>7.10 </B><U><B>Approvals</B></U>. Between the date of this Agreement and the Closing Date, Seller
will (i)&nbsp;cooperate with Buyer and take all reasonable steps to assist Buyer to obtain, as promptly
as practicable, all Approvals and Permits of any Governmental Entities required to consummate the
transactions contemplated by this Agreement and in connection with the Buyer&#146;s expansion of the
operations, hospital licensure and Medicare certification of LMC to encompass and include the
Purchased Assets, and (ii)&nbsp;provide such other information and communications to any Governmental
Entity as may be reasonably requested in connection with Buyer&#146;s application for such Approvals and
Permits. Notwithstanding the foregoing or anything in Section&nbsp;7.10 to the contrary, Buyer
acknowledges that Seller shall not be required to make any CMS Form&nbsp;855 filings as a result of the
Transaction until ten (10)&nbsp;days after the Closing Date.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 8</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The obligations of Seller hereunder are subject to the satisfaction, on or prior to the
Closing Date, of the following conditions unless waived in writing by Seller:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>8.1 </B><U><B>Compliance With Covenants</B></U>. Buyer shall have in all material respects
performed all obligations and complied with all covenants and conditions required by this Agreement
to be performed or complied with by it at or prior to the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>8.2 </B><U><B>HSR Act Waiting Period</B></U>. Seller shall have complied with all waiting periods
under the HSR Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>8.3 </B><U><B>Action/Proceeding</B></U>. No court or any other Governmental Entity shall have
issued an order restraining or prohibiting the transactions herein contemplated; and no
Governmental Entity with jurisdiction over the Hospital shall have commenced or threatened in
writing to commence any action or suit before any court of competent jurisdiction or other
Governmental Entity that seeks to restrain or prohibit the consummation of the transactions herein
contemplated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>8.4 </B><U><B>Representations and Warranties</B></U>. The representations and warranties of Buyer
contained in this Agreement that are qualified by any type of materiality standard shall be true in
all respects, and the representations and warranties of Buyer that are not so qualified shall be
true in all material respects, when made and as of the Closing Date, as though such representations
and warranties had been made as of the Closing Date (unless made only as of a specific date in
which case they shall be true as of such date).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>8.5 </B><U><B>Approvals</B></U><B>. </B>MedCath Corporation shall have obtained any approvals of the
shareholders of MedCath Corporation which it has determined, based upon the advice of counsel, are
required under the Delaware General Corporation Law for MedCath Corporation to authorize Seller to
consummate the transactions contemplated under this Agreement, as well as any other transactions
the approval of which MedCath Corporation elects to seek simultaneously therewith. MedCath
Corporation shall file a preliminary proxy statement with the Securities and Exchange Commission
(the &#147;<U>SEC</U>&#148;), which proxy statement shall, <U><I>inter</I></U> <U><I>alia</I></U>, request and recommend
approval by the shareholders of MedCath Corporation of the transactions described herein, and may,
in MedCath Corporation&#146;s sole discretion, request and recommend approval by the shareholders of
MedCath Corporation of additional transactions. Such proxy shall contain any information which
MedCath Corporation determines is necessary or appropriate for inclusion therein. MedCath
Corporation shall respond as expeditiously as reasonably possible to any comments from the SEC.
Upon clearance by the SEC, MedCath Corporation shall deliver the proxy statement to its
shareholders and call a meeting of MedCath Corporation shareholders. The definitive proxy
statement shall contain the recommendation of the MedCath Corporation board of directors that the
shareholders of MedCath Corporation approve the transactions contemplated herein, which
recommendation shall not be modified or withdrawn prior to the vote of the shareholders of MedCath
Corporation. MedCath Corporation shall use its
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">commercially reasonable efforts to cause the meeting date specified in the proxy statement to
occur on or prior to July&nbsp;31, 2011. In the event that such shareholder meeting date is scheduled
for a date which is after the Outside Date, Seller shall not be entitled to exercise its rights
under Section&nbsp;11.2(a)(ii) hereof. All of the obligations of the board of directors of MedCath
Corporation arising under this Section&nbsp;8.5 shall be subject in all respects to the exercise of
their fiduciary duties, or other comparable duties, to the shareholders of MedCath Corporation.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 9</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The obligations of Buyer hereunder are subject to the satisfaction, on or prior to the Closing
Date, of the following conditions unless waived in writing by Buyer:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.1 </B><U><B>Compliance with Covenants</B></U>. Seller shall have in all material respects
performed all obligations and complied with all covenants and conditions required by this Agreement
to be performed or complied with by it at or prior to the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.2 Pre-Closing Confirmations</B>. Buyer shall have
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) obtained reasonable assurances that following Closing, Buyer will receive all
required Approvals and Permits (which Approvals and Permits shall be effective as of the
Closing) from all Governmental Entities whose approval is required to consummate the
transactions herein contemplated and to expand the operations, hospital licensure and
Medicare certification of LMC to encompass and include the Purchased Assets so that the
Purchased Assets are operated under the hospital licensure and Medicare certification of LMC
as of the Closing; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) complied with all waiting periods under the HSR Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.3 </B><U><B>Action/Proceeding</B></U>. No court or any other Governmental Entity shall have
issued an order restraining or prohibiting the transactions herein contemplated; and no
Governmental Entity with jurisdiction over the Hospital shall have commenced or threatened in
writing to commence any action or suit before any court of competent jurisdiction or other
Governmental Entity that seeks to restrain or prohibit the consummation of the transactions herein
contemplated or otherwise seeks a remedy which would materially and adversely affect the ability of
Buyer to enjoy the use and enjoyment of the Purchased Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.4 </B><U><B>Representations and Warranties</B></U>. All representations and warranties of Seller
contained in this Agreement that are qualified by any type of materiality standard shall be true in
all respects, and all other representations and warranties of Seller that are not so qualified
shall be true in all material respects, when made and as of the Closing Date, as though such
representations and warranties had been made as of the Closing Date (unless made only as of a
specific date in which case they shall be true as of such date).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.5 </B><U><B>Transition Services Agreement</B></U>. Buyer and an Affiliate of Seller shall have
entered into the Transition Services Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.6 </B><U><B>Title Policy</B></U>. At the Closing, Buyer shall have received a pro forma of the
title policy (or marked Title Commitment containing no additional exceptions to title to the Owned
Real Property) from the Title Company in the form described in Section&nbsp;7.8.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.7 </B><U><B>Absence of Certain Changes</B></U><B>. </B>Seller shall have conducted the business of the
Hospital, in all material respects, only in the ordinary course of business and there shall have
occurred no Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.8 </B><U><B>Releases</B></U>. All Encumbrances currently encumbering the Purchased Assets other
than Permitted Encumbrances shall have been duly released by the secured parties and other lien
holders, and UCC-3 releases or termination statements and other lien discharging documents shall
have been properly recorded, the third party shall have committed in writing to promptly release
its lien upon receipt of a specified payoff amount at the Closing, or the recording thereof shall
have been duly arranged pursuant to the relevant secured party&#146;s written authorization allowing
Buyer and/or Seller to file lien-discharging documents without the secured party&#146;s signature.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.9 </B><U><B>Environmental Report</B></U>. Buyer shall have received, at its sole cost and
expense, the Phase I Assessment, prepared by a firm selected by Buyer, and the scope, findings, and
conclusions of such report shall have been reasonably satisfactory to Buyer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>9.10 </B><U><B>Seller&#146;s Deliverables</B></U>. Seller shall have made the deliveries required to be
made by it under Section&nbsp;3.3 hereof.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 10</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>TRANSITIONAL ARRANGEMENTS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>10.1 </B><U><B>Transition Patients</B></U>. To compensate Seller for services rendered and
medicine, drugs and supplies provided on or before the Closing Date (the &#147;<U>Transition Patient
Services</U>&#148;) with respect to patients admitted to the Hospital on or before the Closing Date (or
who were in the Hospital&#146;s emergency department or in observation beds on the Closing Date and
immediately thereafter admitted to the Hospital) but who are not discharged until after the Closing
Date (such patients being referred to herein as the &#147;<U>Transition Patients</U>&#148;), the parties
shall take the following actions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Medicare, Medicaid, TRICARE and Other DRG Transition Patients</U>. As soon
as practicable after the Closing Date, Seller shall deliver to Buyer a schedule itemizing
the Transition Patient Services provided by Seller to Transition Patients whose care is
reimbursed by the Medicare, Medicaid, TRICARE or other third party payor program on a
diagnostic related group basis, case rate or similar basis (each a &#147;<U>DRG Transition
Patient</U>&#148;). Buyer shall pay to Seller an amount equal to (i)&nbsp;the DRG and outlier
payments, the case rate payments or other similar payments received by Buyer on behalf of
each DRG Transition Patient, or, with respect to any DRG Transition Patient covered by the
Acute Care Episode Demonstration Project (the &#147;<U>ACE Demonstration Project</U>&#148;), the
amount payable for the applicable DRG as set forth on <U>Schedule&nbsp;10.1(a)</U>,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">multiplied by a fraction, the numerator of which shall be the total charges for
Transition Patient Services provided to such DRG Transition Patient by Seller, and the
denominator of which shall be the sum of the total charges for all services provided to such
DRG Transition Patient both before and after the Closing Date minus (ii)&nbsp;any deposits or
co-payments made by such DRG Transition Patient to Seller; <U>provided</U>,
<U>however</U>, that with respect to any DRG Transition Patient who is covered by the ACE
Demonstration Project, the total amount of payments received by Buyer for purposes of
allocating payments between the parties under this Section&nbsp;10.1(a) shall not include the
portion of such payments attributable to the professional component of services provided to
such DRG Transition Patient.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Other Patients</U>. As of the Closing Date, Seller shall prepare cut-off
billings for Transition Patient Services provided by Seller for all patients not covered by
Section&nbsp;10.1(a). Seller shall be entitled to receive all amounts collected in respect of
such cut-off billings. Buyer shall remit to Seller any amounts Buyer receives after the
Closing with respect to the Transition Patient Services rendered to such Transition
Patients, including any periodic interim payments or portions thereof applicable to the
period on or prior to the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) All payments required by this Section&nbsp;10.1 shall be made within ten (10)
business days following the conclusion of the preceding month in which any payments are
received by Buyer, accompanied by copies of remittances and other supporting documentation
as reasonably required by Seller. In the event that Buyer and Seller are unable to agree on
any amount to be paid under this Section&nbsp;10.1, then such amount shall be determined by the
accounting firm through the binding process provided in Section&nbsp;2.8 at the joint equal
expense of Buyer and Seller.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Buyer shall use commercially reasonable efforts prior to and promptly
following the Closing to: (i)&nbsp;obtain all Permits and Approvals necessary to bill and collect
for the Transition Patient Services and (ii)&nbsp;to bill and collect for the Transition Patient
services in accordance with the applicable requirements of third party payors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>10.2 </B><U><B>Seller&#146;s Cost Reports</B></U>. Seller will timely prepare all cost reports relating
to Seller for periods ending on or prior to the Closing Date or required as a result of the
consummation of the transactions set forth herein, including terminating cost reports for the
Medicare, Medicaid and TRICARE programs (the &#147;<U>Cost Reports</U>&#148;). Buyer shall forward to
Seller any and all correspondence relating to Cost Reports within five (5)&nbsp;business days after
receipt by Buyer. Buyer shall remit any receipts of funds relating to Cost Reports promptly after
receipt by Buyer and shall forward to Seller any demand for payments within three (3)&nbsp;business days
after receipt by Buyer. Seller shall retain all rights to Agency Receivables and to Cost Reports
including any amounts receivable or payable in respect of such reports or reserves relating to such
reports, including bad debt and cost-report settlements. Such rights shall include the right to
appeal any Medicare determinations relating to Agency Receivables and Cost Reports. Buyer, upon
reasonable notice, during normal business hours and at the sole cost and expense of Seller, will
cooperate with Seller in regard to the preparation, filing, handling and appeal of any Cost
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Reports. Such cooperation shall include the providing of statistics and obtaining files if in
the possession of Buyer and the coordination with Seller pursuant to adequate notice of Medicare
and Medicaid exit conferences or meetings as well as providing to appropriate parties (including
the Provider Reimbursement Review Board), as determined to be reasonably necessary by Seller, a
letter acknowledging that Seller retained all rights to such appeals, and that Buyer agrees that
Seller has the right to pursue such appeals, either on Seller&#146;s behalf, or to the extent required
by Law, as a representative of Buyer. Seller shall retain the originals of Cost Reports,
correspondence, work papers and other documents relating to Cost Reports and the Agency
Receivables. Seller will furnish copies of such documents (other than work papers) to Buyer prior
to the Closing to the extent then existing if requested by Buyer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>10.3 </B><U><B>Employees; Benefits</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) As of the Closing Date, Buyer shall offer employment to all Hospital Employees
who are employed by Seller and not on leave of any sort as of the Closing, <U>provided</U>
that those employees meet the pre-employment screening requirements of Buyer. Buyer shall
offer employment to any Hospital Employee who is employed by Seller and on short-term leave
as of the Closing under one of the programs listed on <U>Schedule&nbsp;5.15</U>, which offer of
employment shall be made effective as of the date such Hospital Employee is cleared for and
returns to active work status, <U>provided</U> that those employees meet the pre-employment
screening requirements of Buyer and, <U>provided</U> <U>further</U>, that Buyer shall have
an obligation to offer employment to any Hospital Employee who is on short term leave, but
if such leave is not a statutory leave, only if such individual returns to active work
status within six (6)&nbsp;months of the Closing Date. The offer of employment to the Hospital
Employees shall be at their existing job duties, titles and responsibilities and at their
existing base wage and salary levels. Except for Accrued PTO and ESR Leave or as provided
in Section&nbsp;10.3(c), no obligations of Seller to or with respect to any of its employees,
including, but not limited to, obligations for accrued vacation, sick and personal leave,
severance pay, obligations under employment contracts, Plans, employee handbooks or
policies, collective bargaining agreements, and applicable Law (including liability for
payroll Taxes and other proper deductions and withholdings) are being assumed by Buyer, and
except as may be specifically required by applicable Law, Buyer shall not be obligated to
continue any employment relationship with any employee for any specific period of time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The term &#147;<U>Hired Employee</U>&#148; as used in this Agreement means a Hospital
Employee who accepts employment with Buyer or one of its Affiliates as of the Closing Date.
All Hired Employees will be retained as employees-at-will (except to the extent that such
Hired Employees are parties to Contracts providing for other employment terms as disclosed
on <U>Schedule&nbsp;5.11</U>, in which case such Hired Employees shall be retained in accordance
with the terms of such Contracts). Buyer shall provide each Hired Employee with employee
benefits, including but not limited to retirement, welfare and paid time off, consistent
with similarly-situated employees at other healthcare facilities owned and/or operated by
Buyer and its Affiliates. With respect to such employee benefits, Buyer shall honor the
Hired Employees&#146; prior service credit under the Seller&#146;s current welfare plans for purposes
of eligibility and satisfying pre-existing condition limitations in the welfare
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">benefit plans of Buyer. Buyer shall honor the Hired Employees&#146; prior length of service
with Seller for purposes of eligibility and vesting in the retirement benefit plans and
other service-based plans of Buyer such as paid time off, but shall not accrue benefits or
make contributions to such plans with respect to any such prior service. For purposes of
retirement benefit plans offered by Buyer, such vesting credit shall be extended at the rate
of one (1)&nbsp;year of credit for each whole twelve-month period elapsed since each Hired
Employee&#146;s most recent date of hire with Seller as of Closing. Buyer shall carry over, and
give credit for, the Accrued PTO and ESR Leave for the Hired Employees to the extent the
value of such time is included in the determination of the Final NWC Calculation.
Participation in Buyer&#146;s employee programs and plans described in this Section&nbsp;10.3 shall
begin as soon as administratively feasible after the Closing Date for participating Hired
Employees (and eligible dependents) and for all other Hired Employees who, given their
service with Seller, have met the age and service requirements for participation under
Buyer&#146;s programs and plans. Buyer shall employ a sufficient number of Hired Employees at
the Hospital for at least a 90-day period following the Closing Date so as not to constitute
a &#147;plant closing&#148; or &#147;mass layoff&#148; (as those terms are used in the Worker Adjustment and
Retraining Notification Act, 29 U.S.C. &#167; 2101 <I>et seq</I>., the &#147;<U>WARN Act</U>&#148;), with respect
to the Hospital. Buyer shall be liable and responsible for any notification required under
the WARN Act (or under any similar state or local Law) and shall indemnify Seller and its
Affiliates from any claims arising out of a breach of this covenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Buyer shall provide continued health and medical coverage to the extent
required under Section&nbsp;4980B of the Code and Sections&nbsp;601 through 608 of ERISA
(&#147;<U>COBRA</U>&#148;) to each current or former employee of the Hospital (and their spouses,
dependents and beneficiaries) who is classified as an &#147;M&#038;A Qualified Beneficiary&#148; (as
defined in Treasury Regulation&nbsp;Section&nbsp;54.4980B-9, Q&#038;A 4), each of whom is listed on
<U>Schedule&nbsp;10.3</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Seller shall retain the responsibility for payment of all medical,
dental, vision, health and disability claims incurred by any Hired Employee prior to the
date that such Hired Employee terminates employment with the Seller (his or her
&#147;<U>Separation Date</U>&#148;), and Buyer does not assume any liability with respect to such
claims. On or after the applicable Separation Date, all medical, dental, vision, health and
disability claims incurred by Hired Employees in Buyer&#146;s employ will be determined under
Buyer&#146;s benefit plans. Buyer agrees that it shall use its best efforts, to the extent
commercially reasonable, upon presentation of an Explanation of Benefits (EOB)&nbsp;by the Hired
Employees and their eligible dependents, to cause them to receive credit under Buyer&#146;s
health care plans for any amounts paid toward deductibles and out-of-pocket maximums by such
Hired Employees and enrolled dependents for the portion of the current plan year preceding
the Closing under a health care plan maintained by the Seller.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Notwithstanding any provision herein to the contrary, no term of this Agreement
shall be deemed to (i)&nbsp;create any Contract with any Hired Employee, (ii)&nbsp;give any Hired
Employee the right to be retained in the employment of Buyer or any of its Affiliates, or
(iii)&nbsp;interfere with the right of Buyer to terminate employment of any Hired
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Employee at any time. Nothing in this Agreement shall diminish the right of Buyer to
change or terminate its policies regarding salaries, benefits and other employment matters
at any time or from time to time. The representations, warranties, covenants and agreements
contained herein are for the sole benefit of the parties hereto, and the Hired Employees are
not intended to be and shall not be construed as beneficiaries hereof. Pursuant to the
&#147;Standard Procedure&#148; provided in Section&nbsp;4 of Revenue Procedure 2004-53, (i)&nbsp;Buyer and
Seller shall report on a predecessor/successor basis as set forth therein, (ii)&nbsp;Seller will
not be relieved from filing a Form W-2 with respect to any Hired Employees, and (iii)&nbsp;Buyer
will undertake to file (or cause to be filed) a Form W-2 for each such Hired Employee with
respect to the portion of the year during which such Hired Employees are employed by Buyer
that includes the Closing Date, excluding the portion of such year that such Hired Employee
was employed by Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>10.4 </B><U><B>Misdirected Payments</B></U>. Seller and Buyer covenant and agree to remit, with
reasonable promptness, to the other any payments received, which payments are on or in respect of
accounts or notes receivable owned by (or are otherwise payable to) the other. In addition, and
without limitation, in the event of a determination by any Governmental Entity or third-party payor
that payments to the Seller or the Hospital resulted in an overpayment or other determination that
funds previously paid by any program or plan to Seller or the Hospital must be repaid, Seller shall
be responsible for repayment of said monies (or defense of such actions) if such overpayment or
other repayment determination was for services rendered on or prior to the Closing Date and Buyer
shall be responsible for repayment of said monies (or defense of such actions) if such overpayment
or other repayment determination was for services rendered after the Closing Date. In the event
that, following Closing, Buyer suffers any offsets against reimbursement under any third-party
payor or reimbursement programs due to Buyer relating to amounts owing under any such programs by
Seller or any of its Affiliates, Seller shall immediately upon demand from Buyer pay to Buyer the
amounts so billed or offset. These obligations shall be in addition to any other remedies
available herein.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 11</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ADDITIONAL AGREEMENTS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.1 </B><U><B>Allocations</B></U>. Buyer and Seller shall reasonably agree prior to the Closing
Date upon an allocation methodology of the Purchased Assets among the various classes of assets in
accordance with the provisions of Section&nbsp;1060 of the Code and applicable Treasury Regulations, and
attach such allocation hereto as <U>Schedule&nbsp;11.1</U>. The parties agree that any Tax returns, or
other Tax information they may file or cause to be filed with any Governmental Entity shall be
prepared and filed consistent with such agreed upon allocation. In this regard, the parties agree
that, to the extent required, they will each properly prepare and timely file Form&nbsp;8594 in
accordance with Section&nbsp;1060 of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.2 </B><U><B>Termination Prior to Closing</B></U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;This Agreement and the transactions contemplated by this Agreement may be
terminated as follows:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) by mutual consent in writing of Seller and Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) by Buyer or Seller at any time after July&nbsp;31, 2011 (the &#147;<U>Outside
Date</U>&#148;), if the Closing has not occurred by such date subject however to the
right of Buyer or Seller to extend the Outside Date as set forth below;
<U>provided</U>, that the right to terminate this Agreement under this Section
11.2(a)(ii) is not available to any party whose failure to fulfill any obligation
under this Agreement has been the cause of, or resulted in, the failure of the
Closing to occur by such date, <U>provided further</U>, that if the Closing has not
occurred due to or related to either (x)&nbsp;any formal or informal action, review,
investigation or proceeding by any Governmental Entity of any Person or (y)&nbsp;because
MedCath Corporation shall not have obtained any approvals of the shareholders of
MedCath Corporation which it has determined in its reasonable discretion are
required under the Delaware General Corporation Law for MedCath Corporation to
authorize Seller to consummate the transactions contemplated under this Agreement,
then in either of such events, Buyer or Seller may elect, by providing written
notice to the other party hereto, to extend the Outside Date to September&nbsp;30, 2011,
<U>provided</U> that the right to so extend the Outside Date under this Section
11.2(a)(ii) is not available to any party whose failure to fulfill any obligation
under this Agreement has been the cause of, or resulted in, the failure of the
Closing to occur by July&nbsp;31, 2011;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) by Seller if Buyer breaches in any material respect any of the
representations, warranties, covenants or other agreements of Buyer contained in
this Agreement, which would give rise to the failure of a condition set forth in
Section&nbsp;8.1, which breach cannot be or has not been cured within fifteen (15)&nbsp;days
after the giving of written notice by Seller to Buyer specifying such breach;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) by Buyer if Seller breaches in any material respect any of the
representations, warranties, covenants or other agreements of Seller contained in
this Agreement, which would give rise to the failure of a condition set forth in
Section&nbsp;9.1, which breach cannot be or has not been cured within fifteen (15)&nbsp;days
after the giving of written notice by Buyer to Seller specifying such breach;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) by Buyer or Seller, if any court or any other Governmental Entity
issues an order restraining or prohibiting such party from consummating the sale and
purchase of the Purchased Assets as provided herein and such order becomes final and
non-appealable; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) by Buyer if a Material Adverse Effect shall have occurred since the
date of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event that this Agreement is terminated pursuant to Section&nbsp;11.2(a), all
further obligations of the parties under this Agreement shall terminate; <U>provided</U>
that nothing in this Section&nbsp;11.2 shall relieve Seller or Buyer of any liability for an
intentional breach of any covenant in this Agreement prior to the date of termination, and
the parties shall be entitled to seek and recover damages for such matters and to seek the
remedy of
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">specific performance as set forth in Section&nbsp;12.3, provided however, the right to seek
damages and/or rights to specific performance shall be subject to the limitations set forth
in Articles 11 and 12 of this Agreement. Further, notwithstanding anything in this Section
11.2, or any other Section of this Agreement, to the contrary, in no event shall Seller have
any liability to Buyer, and Buyer shall have no claim against Seller, for damages of any
type or nature arising from any violation or breach of any representations or warranties
made by Seller to Buyer in this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.3 </B><U><B>Buyer Preservation and Seller Access to Records After the Closing</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) After the Closing, Buyer shall keep and preserve in their original form all
medical and other records of the Hospital existing as of the Closing and transferred to
Buyer hereunder for such period as required by applicable Law. For purposes of this
Agreement, the term &#147;records&#148; includes all documents, electronic data and other compilations
of information in any form. Buyer acknowledges that as a result of entering into this
Agreement and operating the Hospital it and its Affiliates will gain access to patient and
other information which is subject to rules and regulations regarding confidentiality.
Buyer shall abide by any such rules and regulations relating to the confidential information
that it acquires. Buyer shall maintain the patient records held at the Hospital or
delivered to Buyer at Closing at the Hospital after Closing in accordance with applicable
Law (including, if applicable, Section&nbsp;1861(v)(i)(I) of the Social Security Act (42 U.S.C. &#167;
1395(V)(1)(i)), and requirements of relevant insurance carriers, all in a manner consistent
with the maintenance of patient records generated at the Hospital after Closing. Upon
reasonable notice, during normal business hours and upon the receipt by Buyer of appropriate
consents and authorizations, Buyer shall afford to representatives of Seller, including its
counsel and accountants, full and complete access to, and the right to make copies of, the
records transferred to Buyer at the Closing (including access to patient records in respect
of patients treated by Affiliates of Seller at the Hospital), including providing a
reasonable location within the Hospital to conduct its review of such records;
<U>provided</U>, <U>however</U>, that no consents or authorizations shall be necessary
with respect to the Hospital&#146;s financial records and Tax records necessary for Seller to
prepare financial statements, cost reports and Tax returns. Buyer shall reasonably
cooperate with Seller and its agents in connection with the preparation of financial
statements, costs reports and Tax returns relating to the period prior to Closing. In
addition, Seller shall be entitled to remove from the Hospital any such patient records, but
only for purposes of pending litigation involving a patient to whom such records refer, as
certified in writing prior to removal by counsel retained by Seller in connection with such
litigation. Any patient records so removed from the Hospital shall be promptly returned to
Buyer following its use by Seller.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Buyer shall reasonably cooperate with Seller and its insurance carriers in
connection with the defense of claims made by third parties against Seller in respect of
alleged events occurring while Seller operated the Hospital; <U>provided</U>, Seller shall
reimburse Buyer its reasonable and documented out-of-pocket third-party expenses incurred in
providing such cooperation. Such cooperation shall include, without limitation, making all
of the Buyer&#146;s employees reasonably available for interviews,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">depositions, hearings and trial; and making all of the Buyer&#146;s employees reasonably
available to assist in the securing and giving of evidence and in obtaining the presence and
cooperation of witnesses, all of which shall be done without payment of any fees to Buyer or
its employees or the payment of any of Buyer&#146;s internal expenses; <U>provided</U>,
<U>however</U>, that Seller shall pay all reasonable and documented out-of-pocket
third-party expenses incurred by such employees (including for travel). In addition, Seller
shall be entitled to remove from the Hospital any records, but only for purposes of pending
litigation involving the Person to whom such records refer, as certified in writing prior to
removal by counsel retained by Seller in connection with such litigation. Any records so
removed from the Hospital shall be promptly returned to Buyer following their use by Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.4 </B><U><B>Reproduction of Documents</B></U>. This Agreement and all documents relating hereto,
including (i)&nbsp;consents, waivers and modifications which may hereafter be executed, (ii)&nbsp;the
documents delivered at the Closing, and (iii)&nbsp;financial statements, certificates and other
information previously or hereafter furnished to Seller or Buyer, may, subject to the provisions of
Section&nbsp;12.8, be reproduced by Seller and by Buyer by any photographic, photostatic, microfilm,
micro-card, miniature photographic or other similar process and Seller and Buyer may destroy any
original documents so reproduced. Seller and Buyer agree and stipulate that any such reproduction
shall be admissible in evidence as the original itself in any judicial, arbitral or administrative
proceeding (whether or not the original is in existence and whether or not such reproduction was
made by Seller or Buyer in the regular course of business) and that any enlargement, facsimile or
further reproduction of such reproduction shall likewise be admissible in evidence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.5 </B><U><B>Tax Matters</B></U>. Following the Closing, the parties shall cooperate fully with
each other and shall provide to the other, as reasonably requested by and at the expense of the
requesting party, all information, records or documents relating to Tax liabilities of the
requesting party for all periods ending on or prior to the Closing and shall preserve all such
information, records and documents (to the extent a part of the assets exchanged and delivered at
Closing) at least until the expiration of any applicable statute of limitations or extensions
thereof; <U>provided</U>, that neither party shall be required to provide any of its income Tax
returns (or supporting materials including working papers and Tax provisions) or those of any
Affiliate. Each party shall retain all Tax returns and supporting materials received pursuant to
Section&nbsp;2.1 at least until the expiration of any applicable statute of limitations or extensions
with respect thereto and shall not destroy such items without first offering such items back to the
other party prior to destruction. Buyer and Seller agree to elect the standard procedure under
Revenue Procedure 2004-53 for information returns to employees and under Revenue Procedure 99-50
for information reporting to non-employees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.6 </B><U><B>Consented Assignment and Permits</B></U>. Buyer shall be responsible for obtaining
any and all consents to assign any Assumed Contract and any and all Permits and Approvals necessary
or desirable in connection with the transactions contemplated hereby. However, if any such consent
to assignment of an Assumed Contract is not obtained as of the Closing, such Assumed Contract will
still be assigned to and assumed by Buyer under this Agreement effective as of the Effective Time.
Further, at the request of Buyer, Seller will cooperate in any reasonable
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">arrangement with Buyer designed to provide for Buyer the benefits and obligations under any
such Assumed Contract, including enforcement of any and all rights of Seller against the other
party or parties thereto arising out of the breach or cancellation by such other party or
otherwise.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.7 </B><U><B>Use of Controlled Substance Permits</B></U>. To the extent permitted by applicable
law, Buyer shall have the right, for a period not to exceed one hundred twenty (120)&nbsp;days following
the Closing Date, to operate under the licenses and registrations of Seller relating to controlled
substances and the operations of pharmacies and laboratories, until Buyer is able to obtain such
licenses and registrations for itself. In furtherance thereof, Seller shall execute and deliver to
Buyer at or prior to the Closing a limited power of attorney substantially in the form of
<U>Exhibit&nbsp;A</U> hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.8 </B><U><B>Risk of Loss; Preclosing Casualty</B></U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The risk of loss or damage to any of the Purchased Assets, the Hospital and all other
property, transfer of which is contemplated by this Agreement, shall remain with Seller until the
Closing and Seller shall maintain its insurance policies covering the Purchased Assets, the
Hospital and all other property through the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If, prior to the Closing, all or any part of the Hospital is partially destroyed or
damaged by fire or the elements or by any other cause where such damage or destruction is in the
aggregate (the &#147;<U>Aggregate Damage</U>&#148;) less than ten percent (10%) of the Interim Cash Purchase
Price and such damage or destruction would not reasonably be expected to materially interfere with
or disrupt operations at the Hospital in a manner which, individually or in the aggregate,
constitutes a Material Adverse Effect, the parties&#146; duties and obligations under this Agreement
shall not be affected and the Closing shall proceed as scheduled; <U>provided</U>,
<U>however</U>, Seller shall assign, transfer and set over to Buyer or its designated Affiliate
all of Seller&#146;s right, title and interest in and to any insurance proceeds on account of such
damage or destruction, including without limitation the proceeds of Seller&#146;s business interruption
insurance policy, and the amount of the Interim Purchase Price shall be reduced by the amount of
any deductibles under such insurance policies. If, prior to the Closing, all or any part of the
Hospital is destroyed or damaged by fire or the elements or by any other cause where the Aggregate
Damage exceeds ten percent (10%) of the Interim Cash Purchase Price or where such damage or
destruction could reasonably be expected to materially interfere with or disrupt operations at the
Hospital in a manner which, individually or in the aggregate, constitutes a Material Adverse
Effect, Buyer may elect to (i)&nbsp;purchase the Hospital, and the Closing shall proceed as scheduled
(<U>provided</U>, <U>however</U>, at the Closing, Seller shall assign, transfer and set over to
Buyer all of Seller&#146;s right, title and interest in and to any insurance proceeds on account of such
damage or destruction, including without limitation the proceeds of Seller&#146;s business interruption
insurance policy, and the amount of the Interim Purchase Price shall be reduced by the amount of
any deductibles under such insurance policies) or (ii)&nbsp;terminate the Agreement by the delivery of a
written notice to Seller on or before the scheduled date of Closing (the &#147;<U>Casualty Termination
Notice</U>&#148;). If Buyer and Seller are unable to agree upon the amount of the Aggregate Damage, the
amount of the Aggregate Damage shall be determined by a consulting firm mutually selected by Seller
and Buyer (the &#147;Independent Consultant&#148;) pursuant to Section&nbsp;11.8(c).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If pursuant to Section&nbsp;11.8(b), the amount of the Aggregate Damage (and any applicable
Interim Cash Purchase Price adjustment) is to be determined by the Independent Consultant, within
fifteen (15)&nbsp;calendar days after the occurrence of the damage to the Hospital (the &#147;<U>Submittal
Date</U>&#148;), each party shall submit to the other party and to the Independent Consultant its
proposed Aggregate Damage (and any applicable Interim Cash Purchase Price adjustment) as a result
of the event(s) contemplated by Section&nbsp;11.8(b), along with a detailed description of the basis for
such amount and any applicable adjustment. Within ten (10)&nbsp;calendar days after the Submittal Date
(the &#147;<U>Decision Date</U>&#148;), the Independent Consultant, acting as an expert and not as an
arbitrator, shall determine the definitive amount of the Aggregate Damage, taking into account any
submissions by Seller or Buyer by the Submittal Date. The decision of the Independent Consultant
as the amount of Aggregate Damage shall be conclusive and binding as between Buyer and Seller, and
the costs of such review shall be borne equally by Seller and Buyer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.9 </B><U><B>Change of Name</B></U>. On or before the Closing Date, Seller shall (a)&nbsp;amend its
charter and take all other actions necessary to change its name to one sufficiently dissimilar to
Seller&#146;s present name to avoid confusion, and (b)&nbsp;take all actions requested by Buyer to enable
Buyer to use any names acquired by Buyer at the Closing. From and after the Closing Date, Seller
shall make no further use of (i)&nbsp;the name &#147;Heart Hospital of New Mexico, LLC&#148; or any derivative
thereof, or (ii)&nbsp;any other name that is sufficiently similar to &#147;New Mexico Heart Hospital, LLC&#148; so
as to potentially cause confusion.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.10 </B><U><B>Transition Services Agreement</B></U>. As of Closing, Affiliates of Seller and of
Buyer will execute and deliver the Transition Services Agreement (&#147;<U>Transition Services
Agreement</U>&#148;), pursuant to which an Affiliate of Seller, or a qualified third-party designated by
an Affiliate of Seller, will provide certain specified transition services to and for the benefit
of Buyer and its Affiliates in substantially the form attached hereto as <U>Exhibit&nbsp;B</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.11 </B><U><B>CVSTAT Program</B></U>. As of Closing, pursuant to a separate License Agreement
(the &#147;<U>CVSTAT License Agreement</U>&#148;), and for and in consideration of the consummation of the
transactions described herein, MedCath Corporation shall grant Buyer a non-exclusive license to use
the trademark &#147;CVSTAT&#148; and to operate the CVSTAT program at the Hospital in the same manner as same
is operated at the Hospital as of the date of this Agreement. The CVSTAT License Agreement shall
not require the payment of any license fees, royalties or other fees, and shall be upon such other
terms and conditions as MedCath Corporation and Buyer may mutually agree.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.12 </B><U><B>Quality Reporting</B></U>. Seller shall submit all quality data required under the
HQI Program to CMS or its agent, and all quality data required under ORYX to The Joint Commission,
for any calendar quarter with reporting deadlines between the date of this Agreement and the
Closing Date. If a calendar quarter ends prior to the Closing Date, but the reporting deadline for
such quarter ends after the Closing Date, Seller shall prepare and submit the quality data for the
Hospital required under the HQI Program and ORYX in accordance with applicable filing deadlines and
in the form and manner required by CMS and The Joint Commission, respectively, or, at the sole
option to Buyer, Seller shall transmit such quality data to Buyer in a form mutually agreeable to
Buyer and Seller or allow Buyer access to such data, to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">enable Buyer to submit quality data for the Hospital required under the HQI Program and ORYX
for such quarter. If the Closing Date falls between the first and last day of a calendar quarter,
Seller shall cooperate with Buyer to ensure that all quality data required to be submitted for the
Hospital under the HQI Program and ORYX for the portion of the quarter during which Seller owned
the Hospital can be aggregated with the quality data for the portion of the quarter during which
Buyer owned the Hospital, to enable Buyer and/or Seller to submit quality data for the Hospital
required under the HQI Program and ORYX in accordance with applicable filing deadlines and in the
form and manner required by CMS and The Joint Commission, respectively.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.13 </B><U><B>Supplemental Insurance</B></U>. Seller, at its sole cost and expense, will obtain a
supplemental insurance policy providing for extended reporting periods for claims made on or after
the Effective Time in respect of events occurring prior to the Effective Time to insure against
professional liabilities of Seller relating to all periods prior to the Effective Time and to have
the effect of converting its current professional liability insurance into occurrence coverage.
Such &#147;tail end&#148; insurance shall have the term and limits of coverage as reflected in <U>Schedule
11.13</U>. Buyer shall be named as an additional insured under the supplemental insurance policy.
Seller shall deliver to Buyer evidence of such supplemental reporting endorsement at Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.14 </B><U><B>Seller&#146;s Covenant Not to Compete</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In consideration for the benefits the Seller (including Manager, MedCath
Corporation and their Affiliates) will receive in connection with the transactions
contemplated herein, which benefits are hereby acknowledged, and as further consideration
for, and as a condition to, the transactions contemplated hereby, and so that Buyer and its
Affiliates shall receive and be able to maintain the benefit of the goodwill, trade secrets
and confidential information which Seller enjoys and has enjoyed in connection with its
operation of the Hospital, and recognizing that the covenants contained herein are not
severable from the goodwill and are granted to Buyer to protect the same, and to otherwise
protect the legitimate business interests of Buyer, Seller covenants and agrees that at all
times from the Closing Date until the fifth (5<SUP style="FONT-size: 85%; vertical-align: text-top">th</SUP>) anniversary of the Closing
Date, Seller (including Manager, MedCath Corporation and their Affiliates) shall not,
directly or indirectly, except as a consultant or contractor to or of Buyer (or any
Affiliate of Buyer), own, lease, manage, operate or control any acute care hospital,
specialty hospital, or ambulatory or other type of surgery center (any of such uses being
referred to herein as a &#147;<U>Competing Business</U>&#148;), within a 25-mile radius of the
Hospital (the &#147;<U>Restricted Area</U>&#148;), without Buyer&#146;s prior written consent (which Buyer
may withhold in its sole and absolute discretion). In the event of a breach of this Section
11.14, Seller recognizes that monetary damages shall be inadequate to compensate Buyer and
Buyer shall be entitled, without the posting of a bond or similar security, to an injunction
restraining such breach, with the costs (including attorneys&#146; fees) of successfully securing
such injunction to be borne by Seller. Nothing contained herein shall be construed as
prohibiting Buyer from pursuing any other remedy available to it under this Agreement for
such breach or threatened breach. All parties hereto hereby acknowledge the necessity of
protection against the competition of Seller (including Manager, MedCath Corporation and
their Affiliates) and that the nature and scope of such protection has been carefully
considered by the parties. Seller further acknowledges
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->53<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">and agrees that the covenants and provisions of this Section&nbsp;11.14 form part of the
consideration under this Agreement and are among the inducements for Buyer entering into and
consummating the transactions contemplated herein. The period provided and the area covered
are expressly represented and agreed to be fair, reasonable and necessary. The consideration
provided for herein is deemed to be sufficient and adequate to compensate for agreeing to
the restrictions contained in this Section&nbsp;11.14. If, however, any court determines that
the foregoing restrictions are not reasonable, such restrictions shall be modified,
rewritten or interpreted to include as much of their nature and scope as will render them
enforceable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding anything in this Section&nbsp;11.14 to the contrary, a Person that
enters into a Change in Control Transaction with MedCath Corporation or its Affiliates shall
not be considered an assignee or successor of Seller or its Affiliates for purposes of this
Section&nbsp;11.14 or otherwise be bound by this Section&nbsp;11.14.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Further, in no event shall any Person (other than an Affiliate of MedCath
Corporation) that purchases one or more hospital facilities from MedCath Corporation or one
of its Affiliates (by the acquisition of either the assets thereof or the equity securities
of such Affiliate) in a transaction that is not a Change in Control Transaction, either be
considered an assignee or successor of Seller or its Affiliates for purposes of this Section
11.14 or otherwise be bound by this Section&nbsp;11.14.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%"><B>11.15 </B><U><B>Information from Virtual Data Room</B></U>. For a period of at least ninety (90)
days from and after Closing, Seller shall make available to Buyer, in a format reasonably
determined by Seller, the materials and information contained at the time of Closing in the virtual
data room that houses due diligence materials and information provided by Seller to Buyer in
connection with the transactions described herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.16 </B><U><B>MedCath Corporation Shareholder Approval; Termination Fee</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In the event that MedCath Corporation shareholder approval is determined by
MedCath Corporation to be required with respect to the sale of the Purchased Assets to Buyer
and the shareholders of MedCath Corporation fail to give such approval by the Outside Date,
then as long as there has been no material default by Buyer with respect to its liabilities
and obligations arising under this Agreement, MedCath Corporation shall reimburse Buyer for
all of its out-of-pocket costs and expenses (including, without limitation, costs and
expenses of accountants, attorneys, engineers, valuation experts and other consultants)
incurred or paid by Buyer in connection with Buyer&#146;s due diligence, Buyer&#146;s negotiation of
this Agreement and, generally, in connection with the transactions described herein, up to
an aggregate maximum amount of $750,000 (the &#147;<U>Expense Reimbursement</U>&#148;). MedCath
Corporation shall reimburse Buyer for such costs and expenses within ten (10)&nbsp;days after the
receipt of an invoice for same from Buyer that schedules the costs and expenses incurred or
paid by Buyer. This Section shall survive any termination of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->54<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In the event that (i)&nbsp;as a result of the exercise of the fiduciary duties, or
other comparable duties, of the board of directors of MedCath Corporation to its
shareholders, the Seller does not fulfill its obligations to consummate the transaction
contemplated by this Agreement and as a result thereof Buyer terminates this Agreement, and
(ii)&nbsp;there has been no material default by Buyer with respect to its liabilities and
obligations arising under this Agreement, then either (x)&nbsp;if within twelve (12)&nbsp;months
following the termination of this Agreement, Seller consummates the sale of either the
Purchased Assets or a majority of the membership interest of the Seller to a third party
(the &#147;<U>Third Party Sale</U>&#148;), then as the sole and exclusive remedy of the Buyer, within
ten days of the consummation of the Third Party Sale, Seller shall pay to Buyer in cash a
termination fee equal to Three Million Two Hundred Thirteen Thousand Dollars ($3,213,000),
in which event Buyer shall not be entitled to any amount under subsection (a)&nbsp;above, or (y)
if the conditions of subsection (x)&nbsp;are not satisfied, then as the sole and exclusive remedy
of the Buyer, Buyer shall be entitled to the Expense Reimbursement. This Section shall
survive any termination of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>11.17 </B><U><B>Post Closing Access to Information</B></U>. Seller and Buyer acknowledge that
subsequent to Closing each party may need access to information or documents in the control or
possession of the other party for the purposes of concluding the transactions herein contemplated,
audits, compliance with governmental requirements and regulations, and the prosecution or defense
of third party claims. Accordingly, Seller and Buyer agree that for a period of six (6)&nbsp;years
after Closing each will make reasonably available to the other&#146;s agents, independent auditors,
counsel, and/or governmental agencies upon written request and at the out-of-pocket expense of the
requesting party such documents and information as may be available relating to the Hospital for
periods prior and subsequent to Closing to the extent necessary to facilitate concluding the
transactions herein contemplated, audits, compliance with governmental requirements and
regulations, and the prosecution or defense of claims. The obligations of Seller in this Section
11.17 shall in all events be subject to and limited by the rights of Seller and its Affiliates set
forth in Section&nbsp;12.23, including but not limited to the rights to dissolve Seller and MedCath
Corporation.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE 12</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>GENERAL</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.1 </B><U><B>Consents, Approvals and Discretion</B></U>. Except as herein expressly provided to
the contrary, whenever this Agreement requires any consent or approval to be given by either party
or either party must or may exercise discretion, the parties agree that such consent or approval
shall not be unreasonably withheld, conditioned or delayed and such discretion shall be reasonably
exercised.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.2 </B><U><B>Legal Fees and Costs</B></U>. In the event either party elects to incur legal
expenses to enforce or interpret any provision of this Agreement by judicial means, the prevailing
party will be entitled to recover such legal expenses, including attorney&#146;s fees, costs and
necessary disbursements, in addition to any other relief to which such party shall be entitled.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->55<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.3 </B><U><B>Choice of Law; Waiver of Jury Trial; Limitation on Damages</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The parties agree that this Agreement shall be governed by and construed in
accordance with the Laws of the State of New Mexico without giving effect to any choice or
conflict of law provision or rule thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHTS IT MAY HAVE TO
DEMAND THAT ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO
THIS AGREEMENT OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER
EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING FROM ANY SOURCE INCLUDING,
BUT NOT LIMITED TO, THE CONSTITUTION OF THE UNITED STATES OR ANY STATE THEREIN, COMMON LAW
OR ANY APPLICABLE STATUTE OR REGULATIONS. EACH PARTY HERETO ACKNOWLEDGES THAT IT IS
KNOWINGLY AND VOLUNTARILY WAIVING ITS RIGHT TO DEMAND TRIAL BY JURY.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding the right of each party to terminate this Agreement pursuant to
Section&nbsp;11.2(a), in the event of a breach by either party of its obligation to consummate
this Agreement or a breach by either party of a covenant prior to or following the Closing,
except as otherwise provided in this Agreement, the non-breaching party shall be entitled to
specific performance to force the breaching party to consummate this Agreement, or to
enforce the covenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) NOTWITHSTANDING ANYTHING TO CONTRARY ELSEWHERE IN THIS AGREEMENT, NO PARTY TO
THIS AGREEMENT (OR ANY OF ITS AFFILIATES) SHALL, IN ANY EVENT, BE LIABLE TO THE OTHER PARTY
(OR ANY OF ITS AFFILIATES) FOR SPECIAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.4 </B><U><B>Benefit; Assignment</B></U>. Subject to provisions herein to the contrary, this
Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
legal representatives, successors and assigns. No party may assign this Agreement without the
prior written consent of the other party; <U>provided</U>, <U>however</U>, that a party hereto
may assign its interest (or a portion thereof) in this Agreement to an Affiliate, but, in such
event, the assignor shall be required to remain obligated hereunder in the same manner as if such
assignment had not been effected.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.5 </B><U><B>Effective Time; Accounting Date</B></U>. The transactions contemplated hereby shall
be effective for accounting purposes as of 11:59&nbsp;p.m. (the &#147;<U>Effective Time</U>&#148;) on the Closing
Date, unless otherwise agreed in writing by Buyer and Seller. The parties will use commercially
reasonable efforts to cause the Closing to be effective as of a month end.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.6 </B><U><B>No Brokerage</B></U>. Buyer and Seller represent to each other that no broker has in
any way been contracted in connection with the transactions contemplated hereby other than Seller&#146;s
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->56<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or a Seller Affiliate&#146;s engagement of Navigant Capital Advisors, LLC, the fees and expenses of
which shall be borne solely by Seller or a Seller Affiliate. Each of Buyer and Seller agrees to
indemnify the other party from and against all loss, cost, damage or expense arising out of claims
for fees or commissions of brokers employed or alleged to have been employed by such indemnifying
party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.7 </B><U><B>Cost of Transaction</B></U>. Whether or not the transactions contemplated hereby
shall be consummated and except as otherwise provided herein, the parties agree as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Except as provided otherwise elsewhere herein, Buyer will pay the fees,
expenses and disbursements of Buyer and its agents, representatives, accountants, and
counsel incurred in connection with the subject matter hereof and any amendments hereto; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Except as provided otherwise elsewhere herein, Seller shall pay the fees,
expenses and disbursements of Seller and its agents, representatives, accountants, and
counsel incurred in connection with the subject matter hereof and any amendments hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Seller shall pay the cost of the title policy and Buyer shall pay the costs
associated with any extended owner&#146;s title insurance policy (including all endorsements).
Buyer shall pay all costs and expenses associated with obtaining the Survey and Phase I
Assessment, required filings under the HSR Act and recording fees and associated Taxes
attendant to recording any deeds conveying title to the Owned Real Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.8 </B><U><B>Confidentiality</B></U>. The Confidentiality Agreement, dated as of April&nbsp;22, 2010
(the &#147;<U>Confidentiality Agreement</U>&#148;), between Ardent Medical Services, Inc. and MedCath
Corporation shall remain in full force and effect. It is understood by the parties hereto that the
information, documents and instruments delivered to Seller by Buyer or the agents of Buyer and the
information, documents and instruments delivered to Buyer by Seller or Seller&#146;s agents are of a
confidential and proprietary nature. Each of the parties hereto agrees that both prior and
subsequent to Closing it will maintain the confidentiality of all such confidential information,
documents or instruments delivered to it by the other party hereto or its agents in connection with
the negotiation of this Agreement or in compliance with the terms, conditions and covenants hereof
and only disclose such information, documents and instruments to its duly authorized officers,
directors, representatives and agents unless (i)&nbsp;compelled to disclose by judicial or
administrative process (including, without limitation, in connection with obtaining the necessary
Approvals of this Agreement and the transactions contemplated hereby) or by other requirements of
Law or (ii)&nbsp;disclosed in an action or proceeding brought by a party hereto in pursuit of its rights
or in the exercise of its remedies hereunder; <U>provided</U>, <U>however</U>, that the parties
hereto shall not disclose any confidential information not required to be disclosed as part of such
permitted disclosure. Each of the parties hereto further agrees that if the transactions
contemplated hereby are not consummated, it will return all such documents and instruments and all
copies thereof in its possession to the other party to this Agreement. Each of the parties hereto
recognizes that any breach of this Section&nbsp;12.8 would result in irreparable harm to the other party
to this Agreement and its Affiliates and that therefore the non-breaching party shall
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->57<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be entitled to an injunction to prohibit any such breach or anticipated breach, without the
necessity of posting a bond, cash or otherwise, in addition to all of their other legal and
equitable remedies. Nothing in this Section&nbsp;12.8, however, shall prohibit the use of such
confidential information, documents or information for the purpose of securing financing to either
party to effect the purchase and sale of assets hereunder or such governmental filings as in the
mutual opinion of Seller&#146;s counsel and counsel for Buyer are (i)&nbsp;required by Law or (ii)&nbsp;otherwise
appropriate. Also, this Section&nbsp;12.8 shall not prohibit the disclosure by either party of any
information, instruments or documents that are required to be filed with Governmental Entities by
or under applicable securities related Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.9 </B><U><B>Press Release</B></U>. Except as required by Law, at all times at or before Closing,
neither Buyer nor Seller will issue any report, statement or release to the public with respect to
this Agreement and the transactions contemplated hereby without the prior written approval of the
other party hereto of the text of any such public report, statement or release. Buyer acknowledges
that MedCath Corporation will file one or more Forms 8-K and proxy statements with the Securities
and Exchange Commission in connection with the transactions contemplated by this Agreement and
shall be entitled to disclose therein such information as MedCath Corporation determines to be
necessary or appropriate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.10 </B><U><B>Waiver of Breach</B></U>. The waiver by either party of breach or violation of any
provision of this Agreement shall not operate as, or be construed to constitute, a waiver of any
subsequent breach of the same or other provision hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.11 </B><U><B>Notice</B></U>. Any notice, demand or communication required, permitted, or desired
to be given hereunder shall be deemed effectively given when personally delivered, when received by
telegraphic or other electronic means (including facsimile transmission) or overnight courier, or
five (5)&nbsp;days after being deposited in the United States mail, with postage prepaid thereon,
certified or registered mail, return receipt requested, addressed as follows:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If to Buyer:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">c/o Ardent Health Services</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">One Burton Hills Boulevard</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Suite 250</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nashville, Tennessee  37215</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:  President and Chief Executive Officer</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:  (615) 296-6351</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>with copy to:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ardent Health Services</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">One Burton Hills Boulevard</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Suite 250</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nashville, Tennessee  37215</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:  General Counsel</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:  (615) 296-6384</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">If to Seller</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">c/o MedCath Corporation</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10720 Sikes Place, Suite 300</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Charlotte, NC  28277</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->58<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:  Chief Financial Officer</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:  (704) 708-5035</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>with a copy to:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Moore and Van Allen PLLC</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">100 North Tryon Street</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Suite 4700</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Charlotte, NC  28202</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:  Hal A. Levinson, Esq.</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:  (704) 331-1159</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or to such other address, and to the attention of such other Person or officer as any party may
designate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.12 </B><U><B>Severability</B></U>. In the event any provision of this Agreement is held to be
invalid, illegal or unenforceable for any reason and in any respect, and if the rights of Buyer and
Seller under this Agreement will not be materially or adversely affected thereby, (i)&nbsp;such
provision will be fully severable; (ii)&nbsp;this Agreement will be construed and enforced as if the
illegal, invalid or unenforceable provision had never compromised a part hereof; (iii)&nbsp;the
remaining provisions of this Agreement will remain in full force and effect and will not be
affected by the illegal, invalid or unenforceable provision or by its severance here from; and (iv)
in lieu of the illegal, invalid or unenforceable provision, there will be added automatically as a
part of this agreement a legal, valid and enforceable provision as similar in terms to the illegal,
invalid or unenforceable provision as may be possible.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.13 </B><U><B>No Inferences</B></U>. Inasmuch as this Agreement is the result of negotiations
between sophisticated parties of equal bargaining power represented by counsel, no inference in
favor of, or against, either party shall be drawn from the fact that any portion of this Agreement
has been drafted by or on behalf of such party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.14 </B><U><B>Divisions and Headings of this Agreement</B></U>. The divisions of this Agreement
into articles, sections and subsections and the use of captions and headings in connection
therewith are solely for convenience and shall have no legal effect in construing the provisions of
this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.15 </B><U><B>No Third-Party Beneficiaries</B></U>. The terms and provisions of this Agreement
are intended solely for the benefit of Seller and Buyer and their respective permitted successors
or assigns, and it is not the intention of the parties to confer, and this Agreement shall not
confer, third-party beneficiary rights upon any other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.16 </B><U><B>Tax and Medicare Advice and Reliance</B></U>. Except as expressly provided in this
Agreement, none of the parties (nor any of the parties&#146; respective counsel, accountants or other
representatives) has made or is making any representations to any other party (or to any other
party&#146;s counsel, accountants or other representatives) concerning the consequences of the
transactions contemplated hereby under applicable Tax related Laws or under the Laws governing the
Medicare program. Each party has relied solely upon the Tax and Medicare
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->59<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">advice of its own employees or of representatives engaged by such party and not on any such
advice provided by any other party hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.17 </B><U><B>Entire Agreement; Amendment</B></U>. This Agreement supersedes all previous
Contracts (other than the Confidentiality Agreement) and constitutes the entire agreement of
whatsoever kind or nature existing between or among the parties representing the within subject
matter and no party shall be entitled to benefits other than those specified herein. As between or
among the parties, no oral statement or prior written material not specifically incorporated herein
shall be of any force and effect. The parties specifically acknowledge that in entering into and
executing this Agreement, the parties rely solely upon the representations and agreements contained
in this Agreement and no others. All prior representations or agreements, whether written or
verbal, not expressly incorporated herein are superseded and no changes in or additions to this
Agreement shall be recognized unless and until made in writing and signed by all parties hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.18 </B><U><B>Seller&#146;s Knowledge</B></U>. When used herein, the phrases &#147;to Seller&#146;s best
knowledge and belief,&#148; &#147;to Seller&#146;s knowledge&#148; and &#147;known&#148; and similar references to Seller&#146;s
knowledge shall mean and refer to all matters with respect to which (a)&nbsp;Seller has received written
notice or (b)&nbsp;the actual knowledge of its officers (or its Affiliate&#146;s officers) listed on
<U>Schedule&nbsp;12.18</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.19 </B><U><B>Multiple Counterparts</B></U>. This Agreement may be executed in two or more
counterparts, each and all of which shall be deemed an original and all of which together shall
constitute but one and the same instrument. The facsimile signature of any party to this Agreement
or any Contract delivered in connection with the consummation of the transactions described herein
or a PDF copy of the signature of any party to this Agreement or any Contract delivered in
connection with the consummation of the transactions described herein delivered by electronic mail
for purposes of execution or otherwise, is to be considered to have the same binding effect as the
delivery of an original signature on an original Contract.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.20 </B><U><B>Disclaimer of Warranties</B></U>. Except as expressly set forth in Article&nbsp;5
hereof, the Hospital and the Purchased Assets transferred to Buyer will be conveyed by Seller and
accepted by Buyer in their physical condition as of the Effective Time, &#147;AS IS, WHERE IS AND WITH
ALL FAULTS, DEFECTS, IMPERFECTIONS, LIABILITIES AND NONCOMPLIANCE WITH LAWS,&#148; WITH NO WARRANTY OF
HABITABILITY OR FITNESS FOR HABITATION, with respect to the Real Property, and WITH NO WARRANTIES,
INCLUDING, THE WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, with respect to
any personal property which is among the Purchased Assets, any and all of which warranties (both
express and implied) Seller hereby disclaims. All of the Purchased Assets shall be further subject
to normal wear and tear on the land, improvements and equipment in the ordinary course of business
up to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.21 </B><U><B>No Survival Period</B></U>. The parties intend to shorten the statute of
limitations and agree that no claims or causes of action may be brought against Buyer or Seller
based upon, directly or indirectly, any of the representations or warranties contained in this
Agreement or any agreements contained in Article&nbsp;6 or Article&nbsp;7 after the Closing.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->60<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.22 </B><U><B>Right to Seek Damages</B></U>. Either party shall be entitled to seek to recover
damages and to recover damages from the other party hereto relating to or arising under this
Agreement and the transactions contemplated hereby, subject to any limitations thereon set forth in
Articles 11 or 12, if, but only if, any of the following is applicable:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The claim is permitted under the terms of Section&nbsp;11.2(b) or Section&nbsp;11.16;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The other party fails to fulfill its obligations under any covenant or other
agreement set forth in this Agreement which by its terms is intended to be performed after
Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) In the case of Buyer, Seller fails to pay or satisfy Excluded Liabilities, and
in the case of Seller, Buyer fails to pay or satisfy Assumed Liabilities, it being
acknowledged that Seller shall retain liability for the Excluded Liabilities and covenants
and agrees that Seller shall be solely responsible and liable therefore and, further, that
Buyer shall not assume the Excluded Liabilities or any obligation or responsibility relating
thereto; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) In the case of Buyer, Seller fails to convey to Buyer at Closing good and
marketable title to the Purchased Assets subject to no Encumbrances other than Permitted
Encumbrances, <U>provided</U>, <U>however</U>, with respect to any matter relating to the
Owned Real Property, Buyer may seek to recover damages and recover damages from Seller under
this Agreement only if Buyer has first asserted (and used commercially reasonable efforts to
recoup) its rights and remedies against the Title Company and the title insurance policy
issued thereby with respect to the Owned Real Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.23 </B><U><B>Right to Take Limited Liability Company and Corporate Action</B></U>.
Notwithstanding anything in this Agreement to the contrary, nothing herein shall prevent or limit,
and Buyer shall not take actions to prevent or limit, (a)&nbsp;Seller at any time after the Effective
Time from being dissolved or liquidated, making payments to its creditors or distributions to its
members, otherwise terminating its existence and/or taking any other limited liability company act,
in each case, as permitted by the New Mexico Limited Liability Company Act, or (b)&nbsp;MedCath
Corporation and its Affiliates from engaging in or agreeing to a Change in Control Transaction or
making payments to its creditors or distributions to its stockholders at any time or, after the
Effective Time, from being dissolved or liquidated, and/ or otherwise terminating its existence, in
each case, as permitted by the General Corporation Law of Delaware. This Section&nbsp;12.23 is not
intended to preclude, and shall not preclude, Buyer from exercising any rights and pursuing any
remedies it might have under this Agreement. To this end, Buyer shall be entitled to initiate
actions and proceedings and pursue claims against Seller and others in accordance with applicable
law to enforce its rights and seek remedies available under this Agreement that are not satisfied
by Seller or MedCath Corporation. Any action or proceeding initiated or commenced by Buyer against
Seller or MedCath Corporation or their Affiliates asserting a right set forth in this Agreement
shall not be deemed to be an action to prevent or limit Seller or MedCath Corporation or other
Affiliates from being dissolved or liquidated.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->61<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>12.24 </B><U><B>Guarantee of Buyer&#146;s Obligations</B></U>. Ardent Medical Services, Inc., as
principal obligor and not merely as a surety, hereby unconditionally guarantees full, punctual and
complete performance by Buyer of all of Buyer&#146;s obligations under this Agreement and each of the
Closing documents subject to the terms hereof and thereof and so undertakes to Seller that, if and
whenever Buyer is in default, Ardent Medical Services, Inc. will on demand duly and promptly
perform or procure the performance of Buyer&#146;s obligations. The foregoing guarantee is a continuing
guarantee and will remain in full force and effect until the obligations of Buyer under this
Agreement have been duly performed or discharged and will continue to be effective or will be
reinstated if any sum paid to Seller must be restored by Seller upon the bankruptcy, liquidation or
reorganization of Buyer. Ardent Medical Services, Inc.&#146;s obligations under this Section&nbsp;12.24 shall
not be affected or discharged in any way by any action or proceeding with respect to Buyer under
any federal or state bankruptcy, insolvency or debtor relief laws. Notwithstanding the foregoing,
the guaranty of Ardent Medical Services, Inc. shall terminate after Buyer&#146;s payment of the Final
Cash Purchase Price to Seller as provided for in Section&nbsp;2.7 of this Agreement if any such payment
is due in connection with the determination of such Final Cash Purchase Price.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">*&nbsp; *&nbsp; *<BR>
<U>&#091;SIGNATURE PAGE FOLLOWS&#093;</U>
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->62<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have caused this Asset Purchase Agreement to be
executed in multiple originals by their authorized officers, all as of the date and year first
above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left"><B>BUYER</B>:&nbsp;</TD>
    <TD colspan="3" align="left"><B>LOVELACE HEALTH SYSTEM, INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Ron Stern
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Ron Stern&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">CFO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left"><B>SELLER</B>:&nbsp;</TD>
    <TD colspan="3" align="left"><B>HEART HOSPITAL OF NEW MEXICO, LLC</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">NM Hospital Management, LLC,
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">its Manager&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">             /s/ O. Edwin French
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">O. Edwin French&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Manager&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="0%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="63%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>GUARANTOR:<BR>
<BR>
ARDENT MEDICAL SERVICES, INC.</B><BR>
a Delaware corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Clint B. Adams
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Clint B. Adams            &nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">CFO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The undersigned hereby agree to be bound by the no-shop provisions set forth in Section&nbsp;7.7 hereof
and the non-compete restrictions set forth in Section&nbsp;11.14 hereof, and also in the case of MedCath
Corporation for purposes of Section&nbsp;11.16 hereof:
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="0%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="63%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>NM Hospital Management, LLC</B><BR>
a North Carolina limited liability company<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ O. Edwin French
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">O. Edwin French&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Manager&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="0%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="63%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>MedCath Corporation</B><BR>
a Delaware corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ O. Edwin French
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">O. Edwin French&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President &#038; CEO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
